hg_153616.1

Basic information about the TSS

---

TSS ID: hg_153616.1 Species: human Chr: chr16		Start: 30069472 End: 30069480 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: LF329320 MA564897 Distance: 24 GeneID: 226 HGNC/MGI_ID: HGNC:414 UniProt_ID: H3BR68

Gene_name: ALDOA Gene_symbol: ALDOA Gene_synonyms: Gene_source: HGNC:414

TATA-Box annotation

---

Distance to TSS:	3716
Nearest PromoterID:	NM_184041
Entrez ID:	226
Nearest Unigene:	Hs.513490
Nearest Refseq:	NM_000034
Nearest Ensembl:	ENSG00000149925
Gene Name:	ALDOA
Gene Alias:	ALDA|GSD12|HEL-S-87p
Gene Description:	aldolase, fructose-bisphosphate A
Gene Type:	protein-coding
CpG%:	0.02
GC%:	0.606965
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ALDOA p2@ALDOA p3@ALDOA p4@ALDOA p5@ALDOA p6@ALDOA p7@ALDOA p8@ALDOA
Sample		p1@ALDOA	p2@ALDOA	p3@ALDOA	p4@ALDOA	p5@ALDOA	p6@ALDOA	p7@ALDOA	p8@ALDOA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	275.06	150.58	33.31	43.64	4.29	15.39	26.10	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	283.25	143.85	37.02	44.31	7.69	18.21	26.30	3.84
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	266.21	132.33	35.30	54.21	4.82	20.06	26.62	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	288.16	119.13	34.10	49.27	6.65	20.17	23.08	2.08
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	315.40	125.08	32.85	45.89	7.42	15.07	20.47	3.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	285.87	120.16	36.63	49.03	6.20	22.09	26.16	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	367.79	137.27	61.44	100.66	8.50	31.81	30.07	3.05
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	299.63	118.45	49.41	87.20	7.02	19.14	34.40	3.88
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	321.86	134.21	58.99	86.77	10.69	22.87	31.63	3.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	269.53	64.92	46.95	77.67	11.01	6.38	7.54	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	297.11	66.29	42.04	80.04	6.87	10.11	8.49	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	239.87	52.04	50.41	80.90	6.10	8.54	12.60	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	857.87	379.93	82.53	64.64	0.16	30.95	23.21	8.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	696.27	347.91	90.36	67.36	0.60	31.42	26.31	8.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	817.40	337.23	85.41	71.35	1.10	28.76	26.35	6.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	903.35	378.49	92.05	67.90	1.26	33.95	22.38	12.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	819.68	347.70	101.78	61.37	1.09	38.88	36.69	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	774.88	327.33	79.72	56.10	1.27	28.26	22.36	11.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	759.75	253.25	84.77	44.78	0.00	35.19	17.06	9.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	703.61	297.12	71.61	56.57	0.90	25.88	26.33	6.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	735.09	344.55	84.07	57.20	0.94	28.07	24.59	9.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	613.33	311.76	85.10	67.32	0.52	27.27	26.93	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	755.90	342.01	90.74	63.59	0.78	29.86	27.92	7.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	733.58	345.07	91.49	53.87	0.97	26.21	32.03	6.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	795.38	331.26	86.43	49.28	1.55	28.89	28.89	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	716.27	288.03	86.72	58.24	0.63	27.22	29.44	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	743.42	266.49	87.91	60.44	0.55	24.73	23.63	6.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	786.94	321.80	86.99	61.06	0.94	26.17	34.89	5.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	712.96	291.87	75.43	56.53	1.13	22.45	23.42	4.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	747.57	318.50	83.97	58.63	1.27	26.60	27.87	9.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	782.95	297.06	80.18	56.94	1.47	31.61	22.40	9.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	818.65	307.14	88.70	57.05	1.17	30.48	24.23	4.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	784.18	314.64	76.39	55.50	1.27	23.64	21.10	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	707.76	287.82	103.75	63.01	1.81	39.26	25.07	8.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	741.60	305.54	81.71	62.83	0.75	27.49	22.44	8.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	814.21	328.44	75.69	54.80	1.53	21.46	23.38	8.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	755.18	308.41	77.87	61.72	1.84	22.28	24.73	6.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	772.10	326.81	88.05	61.45	2.01	30.02	22.37	11.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	713.07	313.32	84.81	57.26	0.81	31.60	28.09	5.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	694.98	281.59	67.46	47.77	1.44	28.09	22.57	7.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	773.77	313.37	83.28	58.58	0.24	30.82	25.17	7.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	689.52	291.91	91.79	60.31	0.44	29.13	27.67	8.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	678.87	264.46	67.91	47.66	0.63	20.88	20.88	9.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	838.47	311.72	79.20	54.72	1.40	21.15	20.28	8.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	728.60	305.38	81.71	54.41	0.60	25.90	24.09	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	747.73	265.45	70.03	56.07	0.70	22.57	21.87	10.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	810.40	276.61	73.41	44.86	0.96	26.39	20.63	6.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	722.18	261.69	68.25	46.50	0.00	27.42	24.74	7.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	827.28	277.43	69.66	45.48	0.24	28.49	21.78	5.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	653.30	231.52	59.65	41.85	1.01	21.64	20.83	6.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	732.71	266.64	76.65	47.34	0.82	21.73	13.32	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	842.13	275.30	78.50	55.82	0.44	21.57	14.45	11.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	69.96	83.95	13.99	0.00	41.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	656.13	289.56	79.49	58.20	1.06	29.45	19.16	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	500.06	230.31	86.82	43.41	0.66	20.21	18.56	6.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	425.34	199.67	90.61	36.07	0.84	19.30	14.26	13.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	610.79	259.01	122.16	45.46	0.92	30.31	13.78	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	573.02	228.50	75.84	58.99	0.32	25.28	17.18	9.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	599.62	229.96	70.66	45.61	0.64	22.48	23.12	7.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	679.90	264.04	104.67	51.24	1.57	30.80	19.80	7.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	475.21	193.18	79.67	40.89	0.71	23.97	11.99	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	441.34	200.20	68.42	54.40	0.56	16.82	12.34	8.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	734.84	267.50	74.84	25.48	0.00	17.52	8.76	22.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	529.70	211.34	70.33	48.59	1.02	17.67	8.83	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	566.34	238.49	84.48	50.04	0.65	20.79	11.05	12.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	404.68	230.38	77.74	41.18	0.00	19.88	9.23	7.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	210.13	64.66	0.00	0.00	0.00	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	86.87	31.59	39.49	0.00	0.00	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	330.05	316.89	95.07	62.40	0.49	15.11	15.11	10.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	327.77	292.56	94.22	70.41	0.00	21.32	16.86	4.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	326.03	323.22	94.76	59.58	0.47	20.64	9.85	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	468.63	418.29	111.61	76.50	0.00	16.56	9.94	10.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	390.70	322.95	94.04	62.80	0.00	17.01	15.16	10.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	404.50	337.85	93.25	69.10	0.61	14.06	12.84	5.50
Adipocyte - breast, donor1	11376-118A8	275.27	453.29	30.41	13.94	1.43	5.70	5.70	4.75
Adipocyte - breast, donor2	11327-117E4	594.38	1105.18	35.29	25.35	8.34	7.06	9.30	10.59
Adipocyte - omental, donor1	11473-119C6	346.31	491.86	16.54	8.40	3.56	7.25	6.11	4.45
Adipocyte - omental, donor2	11474-119C7	319.18	517.26	19.43	20.18	0.75	4.48	5.98	5.98
Adipocyte - omental, donor3	11475-119C8	411.95	595.49	16.08	11.39	10.05	9.38	9.38	11.39
Adipocyte - perirenal, donor1	11476-119C9	426.82	480.41	34.45	24.88	1.91	7.02	8.93	8.93
Adipocyte - subcutaneous, donor1	11259-116F8	591.53	881.80	19.79	12.09	7.70	4.40	8.80	13.19
Adipocyte - subcutaneous, donor2	11336-117F4	344.14	515.30	31.61	29.36	0.90	4.97	4.06	7.68
Adipocyte - subcutaneous, donor3	11408-118E4	750.54	812.40	7.99	5.04	10.95	4.69	7.12	5.39
Adipocyte differentiation, day04, donor1	13019-139D4	262.07	376.08	32.46	23.47	0.39	6.26	4.50	4.30
Adipocyte differentiation, day04, donor2	13022-139D7	259.44	252.23	54.56	26.77	0.51	7.72	6.18	4.12
Adipocyte differentiation, day04, donor3	13025-139E1	390.00	291.32	43.77	31.50	0.84	5.58	5.85	2.51
Adipocyte differentiation, day04, donor4	13028-139E4	335.64	305.66	27.63	18.81	1.76	8.23	8.23	2.94
Adipocyte differentiation, day08, donor1	13020-139D5	787.76	785.51	25.34	17.21	11.58	8.20	30.97	7.32
Adipocyte differentiation, day08, donor2	13023-139D8	454.12	326.95	37.12	21.95	1.94	8.71	9.36	5.81
Adipocyte differentiation, day08, donor3	13026-139E2	389.23	339.64	16.53	9.60	4.80	7.46	6.93	8.00
Adipocyte differentiation, day08, donor4	13029-139E5	707.23	550.32	33.94	13.35	5.56	10.02	17.25	9.46
Adipocyte differentiation, day12, donor1	13021-139D6	1505.11	1247.68	28.28	14.56	23.29	10.40	39.09	14.14
Adipocyte differentiation, day12, donor2	13024-139D9	611.84	410.66	27.13	19.34	3.77	8.79	13.56	6.28
Adipocyte differentiation, day12, donor3	13027-139E3	789.32	687.87	19.96	8.18	10.80	4.91	13.74	7.85
Adipocyte differentiation, day12, donor4	13030-139E6	887.23	682.02	15.22	8.53	7.92	5.18	18.27	9.13
Alveolar Epithelial Cells, donor1	11510-119G7	644.21	491.06	91.27	83.98	3.09	9.50	7.51	3.31
Alveolar Epithelial Cells, donor2	11590-120G6	1177.22	570.86	442.49	334.56	3.23	32.99	16.85	6.10
Alveolar Epithelial Cells, donor3	11671-122G6	1116.55	558.28	89.85	77.87	0.00	11.98	10.78	8.39
Amniotic Epithelial Cells, donor1	11533-120A3	344.16	211.57	6.30	9.53	0.00	0.90	0.72	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	841.77	363.15	20.08	18.41	0.00	8.37	5.02	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	441.51	284.13	7.81	6.57	0.21	3.08	0.00	3.29
Anulus Pulposus Cell, donor1	11248-116E6	357.47	300.83	27.69	24.03	0.57	9.84	2.86	1.26
Anulus Pulposus Cell, donor2	11463-119B5	428.10	297.81	28.41	16.65	1.22	7.35	4.16	2.69
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	289.35	381.45	19.77	11.68	0.45	4.94	4.04	4.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	339.50	470.61	16.06	16.93	0.43	5.21	3.04	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	286.79	321.04	23.54	0.00	4.28	0.00	0.00	8.56
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	312.37	412.21	21.22	14.35	1.49	4.78	2.69	3.89
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	275.69	457.80	17.71	8.85	0.00	7.59	2.53	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	277.23	299.67	13.86	11.88	0.66	3.96	1.98	5.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	280.70	396.36	15.59	12.02	0.32	5.85	3.25	4.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	294.66	428.64	20.87	10.68	0.49	6.31	3.40	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	290.41	339.10	14.25	11.28	1.19	3.56	2.38	11.28
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	269.30	416.18	17.33	11.30	1.88	4.90	3.01	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	306.96	457.90	12.34	13.79	1.45	6.53	5.81	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	285.86	305.92	6.27	12.54	0.00	5.02	0.00	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	285.98	426.50	13.34	13.51	0.99	4.61	2.14	1.81
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	327.55	420.36	27.30	15.01	1.36	4.09	4.09	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	212.92	255.14	9.80	7.54	0.45	4.83	3.62	2.26
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	306.47	441.49	15.54	10.18	1.07	7.50	4.29	4.29
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	304.00	426.62	13.23	10.58	0.76	5.29	3.02	3.40
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	323.15	377.68	16.84	9.36	0.80	5.35	1.87	3.74
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	293.61	423.35	13.66	11.71	0.00	10.73	2.93	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	284.45	420.12	12.44	11.61	0.66	5.31	4.81	2.32
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	253.35	315.79	12.01	16.81	0.00	4.80	2.40	8.41
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	272.59	477.92	24.78	7.08	0.00	3.54	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	304.47	395.72	15.09	11.32	1.37	4.80	2.23	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	251.70	302.04	16.78	8.39	0.00	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	280.58	407.76	18.45	15.53	0.49	7.28	1.94	5.34
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	308.87	434.47	16.70	15.94	0.76	4.93	3.79	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	266.50	289.52	13.33	4.85	0.00	3.63	3.63	8.48
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	263.93	412.13	22.80	14.82	0.00	5.70	5.70	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	289.66	378.81	10.69	14.11	1.28	5.99	1.92	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	314.35	344.29	12.13	8.78	0.26	4.39	1.81	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	279.65	407.74	21.11	10.32	0.47	6.57	2.35	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	322.19	447.60	16.40	10.93	1.29	7.07	3.22	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	296.08	352.45	14.98	8.56	2.14	4.99	1.43	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	301.25	397.18	12.87	12.87	0.58	8.19	1.17	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	328.47	383.27	14.45	12.95	1.20	6.62	1.20	2.41
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	345.71	302.94	14.26	10.69	0.00	3.56	1.19	9.50
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	314.80	430.24	19.33	18.31	1.02	6.10	5.09	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	324.22	427.88	14.52	14.26	0.25	6.11	2.55	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	317.05	322.77	17.79	8.26	0.64	5.08	4.45	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	286.97	423.33	14.67	12.51	0.43	6.04	4.75	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	297.42	419.99	17.36	13.55	0.64	3.60	2.75	2.33
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	319.27	340.15	15.08	7.54	1.16	4.35	2.61	2.90
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	341.99	469.53	18.89	17.01	1.89	7.56	3.78	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	302.94	405.67	14.75	10.34	0.68	5.26	2.88	3.05
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	229.32	254.80	16.21	11.58	0.00	4.63	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	306.32	454.20	8.45	23.24	0.00	10.56	2.11	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	291.81	371.79	13.51	13.72	0.64	3.65	2.36	4.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	335.13	299.03	16.85	8.42	0.60	5.41	1.80	3.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	249.31	415.52	18.22	16.77	0.73	4.37	5.83	6.56
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	305.05	390.57	14.71	12.41	1.61	5.06	5.29	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	326.44	272.88	15.30	2.55	0.00	7.65	5.10	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	186.35	277.37	9.66	6.61	1.02	3.81	1.78	3.81
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	321.84	410.40	16.93	10.73	1.45	4.54	5.37	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	306.31	347.00	9.79	9.18	1.53	3.06	1.84	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	319.31	424.00	15.30	9.08	0.48	8.13	3.35	5.26
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	309.99	392.04	15.74	10.87	0.44	3.77	2.66	2.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	294.48	271.59	12.21	21.36	3.05	3.05	3.05	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	264.20	382.74	19.39	14.40	0.00	5.54	2.22	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	307.96	386.07	11.39	12.18	0.79	2.91	2.65	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	314.38	322.74	10.90	10.54	0.73	5.09	2.54	2.54
Astrocyte - cerebellum, donor1	11500-119F6	378.89	289.11	30.95	27.51	1.23	16.46	4.79	1.23
Astrocyte - cerebellum, donor2	11580-120F5	520.33	335.99	34.06	34.57	2.23	16.60	8.56	2.40
Astrocyte - cerebellum, donor3	11661-122F5	555.20	368.74	58.10	38.80	1.05	13.00	6.92	2.52
Astrocyte - cerebral cortex, donor1	11235-116D2	249.24	201.48	23.01	27.19	0.70	9.76	5.58	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	478.85	314.49	37.86	46.91	0.49	9.54	3.56	2.91
Astrocyte - cerebral cortex, donor3	11392-118C6	330.99	273.56	19.99	26.25	0.30	6.56	4.33	2.54
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	330.41	529.85	337.29	285.34	0.34	36.01	9.52	2.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	258.08	419.19	298.05	254.20	0.13	31.07	9.27	1.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	261.05	425.94	288.36	276.98	0.11	31.18	6.94	1.02
Basophils, donor1	12241-129G9	227.27	142.80	17.00	15.95	0.00	6.54	1.05	1.31
Basophils, donor2	12242-129H1	161.64	145.04	36.08	21.65	0.36	10.10	1.08	0.36
Basophils, donor3	12243-129H2	319.87	174.63	29.11	22.64	0.44	10.44	5.00	1.76
Bronchial Epithelial Cell, donor1	11511-119G8	648.97	414.60	36.01	40.10	0.43	6.68	0.43	5.17
Bronchial Epithelial Cell, donor2	11591-120G7	2995.02	1151.19	214.88	203.45	0.00	16.92	9.14	18.74
Bronchial Epithelial Cell, donor3	11672-122G7	989.95	502.15	107.60	107.60	0.00	14.35	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	1151.74	622.63	170.72	160.68	0.63	8.79	6.28	9.41
Bronchial Epithelial Cell, donor5	11457-119A8	1538.63	745.92	169.69	176.34	0.62	15.60	10.40	7.28
Bronchial Epithelial Cell, donor6	11461-119B3	1077.76	424.43	112.38	99.26	0.46	7.60	1.61	9.44
Bronchial Epithelial Cell, donor7	11769-123I5	689.01	500.43	72.52	68.38	0.18	6.48	3.06	5.76
Burkitt's lymphoma cell line:DAUDI	10422-106C8	42.36	32.36	141.60	213.53	1.65	59.88	8.35	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	260.85	243.62	295.32	298.35	0.47	47.75	8.62	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	143.26	160.85	118.00	110.64	0.00	42.53	18.23	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	134.45	134.45	144.79	0.00	0.00	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	321.79	148.22	22.54	17.47	0.00	9.02	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	474.21	223.28	29.70	18.56	0.74	10.21	0.74	1.86
CD14+ Monocytes, donor3	11381-118B4	336.55	190.78	26.56	25.69	0.00	7.24	2.41	2.41
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	330.60	150.86	34.81	28.30	0.00	13.02	4.25	2.26
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	318.80	195.98	32.22	32.60	0.76	11.75	2.65	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	282.72	159.77	32.55	26.30	0.33	10.19	0.99	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	714.07	279.99	30.50	20.24	0.14	12.43	1.88	6.50
CD14+ monocytes - mock treated, donor2	11873-125C1	386.53	195.83	14.79	12.67	0.00	9.66	0.60	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	429.72	227.65	20.61	12.79	0.24	11.61	1.18	4.50
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	615.19	225.32	21.43	14.40	0.00	14.23	3.01	4.52
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	397.46	145.18	18.22	9.66	0.00	7.45	0.55	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	410.32	191.65	18.84	12.15	0.00	5.45	1.24	3.97
CD14+ monocytes - treated with BCG, donor1	11860-125A6	620.88	227.72	28.39	21.34	0.00	9.40	1.96	3.92
CD14+ monocytes - treated with BCG, donor2	11870-125B7	448.68	178.40	23.68	13.00	0.00	8.55	1.07	3.92
CD14+ monocytes - treated with BCG, donor3	11880-125C8	341.68	183.46	30.47	18.72	0.44	11.32	2.18	2.83
CD14+ monocytes - treated with Candida, donor1	11868-125B5	592.34	210.25	26.92	17.09	0.00	10.54	1.64	3.51
CD14+ monocytes - treated with Candida, donor2	11878-125C6	437.74	171.61	21.12	17.95	0.00	8.98	1.06	6.86
CD14+ monocytes - treated with Candida, donor3	11888-125D7	442.63	189.70	26.62	22.19	0.00	16.64	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	652.41	263.43	28.56	18.00	0.00	11.01	1.64	6.10
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	395.70	187.18	17.16	11.37	0.00	9.18	1.40	5.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	324.17	170.31	17.91	12.70	0.00	7.29	2.71	4.58
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	713.81	301.54	31.80	19.45	0.00	10.07	2.75	5.49
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	270.54	140.93	15.38	12.89	0.00	8.14	1.58	3.62
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	347.42	175.89	17.89	12.66	0.00	6.55	1.31	3.49
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	634.01	240.75	18.83	17.22	0.00	13.72	1.08	5.65
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	426.73	200.45	22.68	14.83	0.35	12.74	1.57	3.14
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	369.48	195.68	25.67	15.57	0.00	8.00	1.26	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	631.97	249.66	29.94	21.31	0.00	10.66	1.84	3.12
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	396.30	153.24	20.08	9.16	0.35	5.99	4.93	3.87
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	352.30	165.84	14.04	12.72	0.00	8.34	1.32	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	580.84	219.19	26.16	17.09	0.35	9.24	1.39	3.84
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	367.22	170.97	21.93	15.98	0.00	8.92	1.86	3.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	357.38	180.41	30.18	21.12	0.22	8.62	3.45	4.53
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	625.70	231.36	27.85	20.06	5.32	12.28	1.23	3.69
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	256.83	104.08	17.62	10.20	0.23	6.95	0.23	1.85
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	277.46	138.04	16.24	11.37	0.23	7.66	1.39	5.57
CD14+CD16+ Monocytes, donor1	11789-124B7	325.42	251.97	28.77	20.05	0.44	10.46	2.40	4.36
CD14+CD16+ Monocytes, donor2	11801-124D1	444.20	270.26	25.41	16.17	0.00	10.63	1.62	4.39
CD14+CD16+ Monocytes, donor3	11912-125G4	296.33	215.75	34.44	29.24	1.30	12.13	3.03	2.17
CD14+CD16- Monocytes, donor1	11788-124B6	666.80	309.73	79.26	44.38	0.16	17.91	3.58	3.11
CD14+CD16- Monocytes, donor2	11799-124C8	551.00	246.60	74.57	43.84	0.17	18.86	5.76	2.10
CD14+CD16- Monocytes, donor3	11910-125G2	326.20	167.45	45.71	26.09	0.00	8.03	4.46	2.68
CD14-CD16+ Monocytes, donor1	11790-124B8	470.54	332.75	8.17	3.32	0.77	2.30	0.51	3.06
CD14-CD16+ Monocytes, donor2	11800-124C9	526.52	330.66	5.93	2.20	0.00	3.07	0.88	4.61
CD14-CD16+ Monocytes, donor3	11911-125G3	399.83	286.34	8.00	4.00	0.00	2.95	0.42	4.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	79.26	111.78	56.90	34.55	0.00	10.16	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	63.05	118.65	56.95	77.97	0.00	19.66	2.71	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	50.74	125.31	56.96	88.03	0.00	33.14	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	74.63	107.14	45.31	81.02	0.00	15.46	3.20	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	50.93	124.90	58.97	86.84	0.00	24.66	1.61	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	58.26	112.31	50.54	72.30	0.70	17.55	3.51	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	62.75	108.24	57.26	91.77	0.00	25.88	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	114.69	60.64	56.69	0.00	18.46	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	57.53	111.78	22.19	56.71	0.00	6.58	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	63.84	110.99	29.02	38.45	0.00	10.88	2.18	1.45
CD19+ B Cells, donor3	11705-123B4	58.05	103.49	24.74	43.42	0.00	11.61	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	124.45	91.72	16.97	13.74	0.00	5.25	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	109.46	91.88	13.58	15.58	0.00	3.20	0.80	1.60
CD34+ Progenitors, donor1	11545-120B6	105.43	98.40	34.14	36.15	0.00	23.09	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	126.97	94.38	33.71	30.90	0.00	20.23	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	161.95	164.96	111.22	124.37	0.75	37.95	12.78	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	146.11	160.77	130.55	118.83	0.00	45.77	11.95	0.90
CD4+ T Cells, donor1	11225-116C1	87.12	154.25	20.35	34.99	0.00	24.28	2.14	0.00
CD4+ T Cells, donor2	11306-117C1	121.25	282.91	28.17	39.19	0.00	26.94	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	119.86	246.74	33.24	46.97	0.30	21.35	1.52	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	81.93	235.07	106.94	114.09	0.26	23.74	5.36	2.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	101.07	251.32	98.15	95.00	0.00	25.38	4.94	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	81.64	259.29	82.21	89.69	0.00	22.71	3.45	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	78.23	188.69	82.49	97.66	0.00	33.66	3.32	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	89.90	199.46	84.28	122.91	0.00	40.03	2.11	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	121.96	290.07	102.18	131.85	0.00	42.85	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	111.57	279.20	106.36	87.58	0.14	26.74	7.23	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	125.91	278.43	116.59	94.22	0.17	19.66	3.90	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	112.84	269.86	110.91	83.02	0.00	17.89	4.19	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	122.83	267.19	53.80	53.80	0.45	15.69	1.34	3.59
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	126.48	304.32	60.44	67.78	0.35	23.41	3.49	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	105.60	228.35	39.16	57.64	0.00	22.00	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	75.90	196.91	102.88	94.03	0.00	26.56	5.48	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	118.64	235.20	130.69	81.86	0.00	19.53	4.16	1.87
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	115.94	241.91	130.64	87.88	0.00	26.40	4.34	2.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	67.44	160.99	63.90	94.09	0.00	48.13	3.26	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	63.78	163.46	55.20	93.26	0.00	53.59	10.18	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	82.49	188.29	80.70	100.42	0.00	44.83	5.38	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	101.80	297.43	192.29	115.34	0.19	30.22	9.64	3.34
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	73.65	224.63	123.91	100.94	0.00	19.28	7.36	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	86.37	214.99	103.39	86.16	0.00	15.34	7.15	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	69.77	208.81	45.50	71.29	0.00	23.26	3.03	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	107.45	240.89	56.76	65.42	0.00	30.76	3.03	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	74.96	193.94	58.84	68.86	0.00	23.53	4.36	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	96.99	232.09	94.52	110.36	0.00	33.16	3.96	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	86.78	204.02	92.32	87.70	0.00	27.70	3.69	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	64.21	279.16	108.87	100.50	0.00	41.87	6.98	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	103.57	187.20	95.54	128.77	0.00	47.08	5.82	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	74.84	179.63	102.82	121.22	0.00	47.36	4.91	2.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	120.12	207.90	56.98	104.72	0.00	27.72	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	123.91	232.78	91.32	103.50	0.00	37.96	3.58	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	74.79	253.45	105.26	73.40	0.00	26.31	5.54	2.77
CD8+ T Cells, donor1	11226-116C2	76.28	200.37	44.85	34.70	0.00	15.71	3.27	1.96
CD8+ T Cells, donor2	11307-117C2	76.96	269.18	37.17	31.16	0.00	12.76	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	79.03	224.46	42.17	40.15	0.00	18.43	2.52	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	96.12	282.15	107.58	84.87	1.61	9.86	3.67	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	88.67	276.31	94.90	77.88	0.96	7.91	3.35	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	90.29	251.98	93.02	64.57	0.55	11.49	3.83	2.46
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	103.57	360.25	127.59	112.58	2.70	14.71	7.21	2.40
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	126.23	294.22	81.11	68.64	1.20	10.32	2.88	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	103.01	262.86	83.68	68.90	2.27	6.82	4.78	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	119.51	337.88	141.45	113.64	1.96	9.34	5.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	126.60	308.48	149.50	123.97	1.84	14.48	5.53	3.16
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	116.79	305.10	144.46	110.22	2.11	11.02	4.46	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	116.83	317.57	171.77	146.71	0.60	10.57	6.04	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	121.72	298.93	161.52	126.95	2.03	10.17	4.36	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	110.30	301.60	168.65	145.21	1.33	9.86	3.20	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	161.09	184.29	55.59	59.53	0.00	7.88	0.88	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	150.29	189.46	71.05	58.29	1.37	11.84	4.10	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	169.31	182.74	48.48	52.96	1.49	6.71	0.75	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	128.94	273.72	91.12	86.08	1.44	8.28	4.68	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	111.06	268.44	87.18	73.66	1.73	7.77	2.59	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	96.64	242.53	68.59	69.29	0.94	8.72	2.83	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	96.34	308.66	140.39	120.42	2.85	6.34	1.90	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	129.18	298.64	146.40	118.72	1.23	4.31	2.77	4.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	109.32	265.76	138.49	95.53	1.60	5.77	2.24	2.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	112.06	270.40	148.01	123.92	1.91	8.80	4.21	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	107.98	249.07	148.58	117.84	2.36	11.03	3.94	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	102.87	242.81	139.18	108.17	2.27	12.10	3.78	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	134.09	114.82	40.95	29.71	1.61	4.01	2.41	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	128.00	97.22	33.57	29.38	0.70	3.50	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	127.22	117.20	33.06	32.06	0.00	3.01	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	418.55	557.46	3.66	1.83	0.00	3.66	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	419.98	395.77	21.25	17.79	0.00	8.89	4.94	4.94
Cardiac Myocyte, donor3	11686-122I3	902.58	826.50	47.99	36.94	0.95	11.15	11.58	0.63
Chondrocyte - de diff, donor1	11261-116G1	221.87	270.05	70.37	50.61	1.73	19.41	6.59	2.77
Chondrocyte - de diff, donor2	11338-117F6	442.44	584.24	63.61	51.89	1.78	16.70	5.69	6.04
Chondrocyte - de diff, donor3	11410-118E6	449.43	558.65	56.78	34.93	0.11	12.74	5.80	3.07
Chondrocyte - re diff, donor2	11339-117F7	158.46	316.03	76.99	52.82	1.79	12.53	8.06	2.69
Chondrocyte - re diff, donor3	11411-118E7	416.13	450.51	71.98	53.79	1.62	13.75	2.83	6.07
Ciliary Epithelial Cells, donor1	11242-116D9	324.88	258.67	37.53	29.72	0.46	14.57	7.69	2.18
Ciliary Epithelial Cells, donor2	11323-117D9	360.20	380.50	43.18	35.27	0.86	13.89	5.77	3.85
Ciliary Epithelial Cells, donor3	11399-118D4	345.05	330.98	37.26	32.12	0.88	14.69	6.81	2.39
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	236.95	294.73	20.72	24.67	0.73	12.29	5.41	1.74
Corneal Epithelial Cells, donor1	11526-119I5	763.45	552.88	60.16	78.39	0.22	7.03	3.29	2.42
Corneal Epithelial Cells, donor2	11606-120I4	766.74	560.84	63.71	54.60	0.00	2.28	3.41	13.65
Corneal Epithelial Cells, donor3	11687-122I4	709.12	637.03	100.21	109.92	0.51	8.95	3.58	4.09
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	386.16	305.10	24.60	14.20	0.66	4.13	1.32	3.30
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	354.20	316.67	25.55	19.87	0.00	4.10	0.95	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	220.84	403.73	34.51	34.51	0.00	6.90	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	479.47	452.91	37.26	26.89	0.32	5.72	3.13	6.37
Dendritic Cells - plasmacytoid, donor1	11228-116C4	53.98	88.83	25.96	30.75	0.00	15.72	5.47	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	62.02	99.89	28.07	35.25	0.00	15.67	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	39.20	63.88	24.68	30.00	0.00	10.65	2.90	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	530.16	517.32	66.87	66.37	0.33	6.84	6.50	3.50
Endothelial Cells - Aortic, donor1	11263-116G3	494.07	454.75	38.73	29.34	0.00	3.52	5.87	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	380.36	381.49	29.41	22.06	0.00	5.09	3.11	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	405.77	383.75	15.73	20.45	1.18	1.57	1.18	3.54
Endothelial Cells - Artery, donor1	11264-116G4	531.43	470.63	16.58	12.51	0.29	2.33	2.62	5.24
Endothelial Cells - Artery, donor2	11341-117F9	550.32	547.49	45.17	42.59	0.24	4.24	4.94	2.59
Endothelial Cells - Artery, donor3	11413-118E9	562.04	598.86	50.84	46.11	0.35	2.98	4.73	3.51
Endothelial Cells - Lymphatic, donor1	11236-116D3	303.22	280.83	20.17	17.29	0.66	2.88	4.43	3.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	263.80	264.71	14.30	14.30	0.30	1.22	1.83	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	264.14	224.40	14.38	14.94	0.00	1.97	1.69	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	393.41	306.94	7.13	6.54	0.00	2.38	0.89	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	281.16	280.12	25.51	22.39	0.52	2.60	1.04	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	262.31	265.00	2.84	2.98	0.28	0.85	0.00	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	397.72	294.89	19.21	20.41	0.00	2.00	1.20	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	364.79	436.07	9.43	15.72	0.00	0.00	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	326.15	303.04	27.58	27.96	0.75	3.98	2.24	2.73
Endothelial Cells - Umbilical vein, donor2	11324-117E1	379.34	286.13	14.56	17.82	0.22	2.39	2.61	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	501.33	336.10	25.16	26.99	0.37	3.05	2.08	2.44
Endothelial Cells - Vein, donor1	11267-116G7	549.42	551.69	39.81	42.09	2.28	2.28	2.28	4.55
Endothelial Cells - Vein, donor2	11344-117G3	599.31	690.82	62.87	71.25	0.00	9.78	2.79	5.59
Endothelial Cells - Vein, donor3	11416-118F3	588.46	465.05	43.80	46.16	0.79	4.71	4.55	4.71
Eosinophils, donor1	12244-129H3	106.73	152.47	45.74	30.49	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	498.38	462.07	4.95	0.00	0.00	4.95	0.00	1.65
Eosinophils, donor3	12246-129H5	542.16	370.95	3.57	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	681.67	510.40	88.69	105.79	0.98	10.51	0.98	2.44
Esophageal Epithelial Cells, donor2	11587-120G3	990.16	336.99	49.92	49.92	0.00	10.40	0.00	8.32
Esophageal Epithelial Cells, donor3	11668-122G3	1155.08	569.41	65.08	16.27	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	438.84	767.66	50.49	20.94	0.82	14.37	5.75	9.03
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	290.14	611.49	52.44	27.70	2.41	9.85	16.09	51.79
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	322.41	386.33	69.01	34.88	1.19	11.05	11.59	9.53
Fibroblast - Aortic Adventitial, donor1	11245-116E3	348.32	525.26	67.80	34.93	0.61	10.07	10.07	6.31
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	395.77	1248.99	81.47	55.27	1.50	17.20	25.79	3.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	390.13	685.55	48.09	29.21	1.16	11.60	5.70	8.23
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	284.83	329.89	97.49	48.75	0.79	11.59	15.02	6.85
Fibroblast - Aortic Adventitial, donor3	11401-118D6	357.78	495.31	54.81	36.87	0.33	3.32	5.98	3.32
Fibroblast - Cardiac, donor1	11268-116G8	490.82	720.81	68.95	46.27	1.81	14.06	22.68	4.99
Fibroblast - Cardiac, donor2	11345-117G4	995.19	1192.25	56.85	50.78	0.00	12.89	7.58	12.89
Fibroblast - Cardiac, donor3	11417-118F4	474.09	866.65	70.18	37.38	0.79	14.19	5.20	4.57
Fibroblast - Cardiac, donor4	11452-119A3	198.84	264.01	7.88	5.15	0.00	3.64	1.52	1.52
Fibroblast - Cardiac, donor5	11456-119A7	363.96	288.58	14.85	10.91	0.00	3.05	3.55	2.16
Fibroblast - Cardiac, donor6	11460-119B2	417.04	326.08	17.89	13.64	0.45	3.64	2.88	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	245.47	325.86	38.05	28.54	2.81	26.26	6.57	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	254.11	305.88	24.59	19.85	0.43	18.12	8.20	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	435.04	405.75	36.62	60.06	0.00	8.79	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	376.86	339.04	37.36	51.43	1.61	3.92	2.08	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	379.07	240.16	9.33	6.95	1.87	9.16	1.36	0.17
Fibroblast - Dermal, donor1	11269-116G9	341.14	536.01	45.31	37.80	0.94	6.81	6.10	2.11
Fibroblast - Dermal, donor2	11346-117G5	437.25	593.84	57.54	60.85	1.42	6.13	0.94	2.36
Fibroblast - Dermal, donor3	11418-118F5	373.18	425.16	32.16	24.66	0.60	3.51	1.09	1.57
Fibroblast - Dermal, donor4	11450-119A1	388.42	259.21	28.15	28.94	0.68	6.67	2.03	2.03
Fibroblast - Dermal, donor5	11454-119A5	455.32	265.17	50.42	45.01	1.05	13.78	7.50	2.97
Fibroblast - Dermal, donor6	11458-119A9	439.36	308.93	52.30	49.86	0.49	11.04	5.04	2.11
Fibroblast - Gingival, donor1	11237-116D4	289.02	302.97	41.85	28.74	1.04	5.62	2.92	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	269.07	321.47	16.77	9.17	0.26	3.14	2.62	7.07
Fibroblast - Gingival, donor2	11318-117D4	397.99	397.72	36.90	33.34	0.92	5.67	3.03	2.24
Fibroblast - Gingival, donor3	11394-118C8	370.31	278.94	28.04	26.40	0.29	4.45	0.97	1.93
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	229.60	322.06	22.86	25.97	2.08	6.23	4.16	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	335.49	428.88	25.20	19.38	0.35	5.81	3.35	4.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	335.96	292.77	24.94	18.71	2.03	5.46	4.99	2.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	271.27	271.67	27.99	21.23	0.14	2.84	2.03	2.57
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	337.00	376.88	11.29	10.59	0.71	2.47	1.41	3.53
Fibroblast - Gingival, donor7 (control)	11924-125H7	322.18	275.96	23.84	16.38	0.73	4.68	2.92	3.22
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	250.75	278.84	32.18	25.63	1.23	5.32	4.50	3.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	224.43	249.66	27.97	19.64	0.44	3.73	3.51	3.40
Fibroblast - Gingival, donor9 (control)	11927-125I1	358.04	227.30	12.77	6.31	0.44	3.52	2.35	3.82
Fibroblast - Lung, donor1	11270-116H1	535.58	652.49	38.06	31.27	0.00	4.08	2.72	4.08
Fibroblast - Lung, donor2	11347-117G6	202.93	234.27	7.46	20.89	1.49	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	472.30	519.15	34.40	31.02	2.11	4.85	4.43	1.90
Fibroblast - Lymphatic, donor1	11506-119G3	479.82	454.83	39.15	29.16	2.50	6.66	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	520.29	400.01	15.38	33.57	0.00	6.99	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	459.56	464.87	20.99	19.87	0.84	3.64	0.56	1.68
Fibroblast - Mammary, donor1	11540-120B1	365.37	437.63	30.04	30.04	0.41	2.03	2.03	0.81
Fibroblast - Mammary, donor2	11620-122A9	854.76	411.40	51.92	27.96	3.99	3.99	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	595.63	482.46	23.83	17.87	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	348.18	276.80	35.89	32.78	0.78	4.46	1.16	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	428.96	318.84	33.83	28.21	0.76	3.94	2.28	2.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	213.58	257.03	18.67	17.14	0.00	2.14	0.92	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	317.89	314.84	17.94	19.08	1.14	3.05	3.05	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	319.67	440.62	22.95	18.90	0.54	6.75	1.89	4.86
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	254.33	377.50	28.53	23.08	0.81	6.49	3.13	3.83
Fibroblast - Pulmonary Artery, donor1	11250-116E8	400.57	581.95	36.37	25.20	1.11	6.63	6.63	1.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	398.86	417.15	15.04	14.43	1.22	1.22	1.22	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	458.39	394.24	34.08	30.74	1.34	4.68	2.67	4.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	468.50	443.20	25.70	20.16	0.40	7.51	4.74	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	587.01	477.07	58.74	36.71	0.40	13.89	6.95	3.37
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	427.88	388.45	30.20	19.01	0.18	10.48	4.97	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	500.79	624.56	52.23	29.17	0.39	9.07	5.72	2.96
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	507.84	431.73	48.14	33.70	1.50	10.53	9.93	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	427.06	358.83	48.47	26.12	0.97	8.96	5.40	3.67
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	676.97	671.41	100.47	53.15	2.02	18.73	19.74	4.30
Fibroblast - skin normal, donor1	11553-120C5	347.52	469.10	32.00	23.46	0.49	9.52	7.38	2.95
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	322.42	483.62	33.89	22.06	1.00	7.22	11.23	1.20
Fibroblast - skin normal, donor2	11561-120D4	371.51	594.74	36.17	26.82	0.60	14.77	8.24	2.61
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	768.89	833.87	105.18	74.65	2.72	17.23	16.62	4.84
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	488.05	405.28	35.87	22.20	0.75	11.93	3.65	1.74
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	362.93	272.15	23.08	17.44	0.68	11.11	3.59	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	531.07	536.33	47.62	37.44	1.64	9.20	11.82	3.94
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	365.26	526.00	31.74	20.03	1.17	8.42	7.35	2.34
Fibroblast - skin walker warburg, donor1	11554-120C6	452.06	568.62	30.70	24.63	0.51	6.07	5.90	3.20
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	363.82	351.90	50.97	18.35	0.63	10.04	13.96	8.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	376.72	155.12	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	429.66	270.17	2.61	2.61	0.87	0.00	0.00	5.23
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	605.19	255.53	9.19	9.53	0.17	1.21	0.35	2.95
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	591.27	265.71	13.27	21.86	0.52	1.30	0.52	4.94
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	458.90	285.41	18.40	18.40	0.00	2.30	0.00	4.34
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	622.39	317.70	47.46	55.89	4.59	43.64	19.90	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	539.81	313.93	35.09	49.77	2.55	42.11	20.42	7.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	531.73	305.23	51.06	93.00	1.71	53.91	29.10	4.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	254.52	135.67	9.65	20.68	0.83	31.44	7.17	5.24
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	342.72	116.22	11.64	16.44	1.37	20.55	5.25	7.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	551.20	303.73	41.21	67.17	1.19	40.62	15.26	4.16
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	181.86	125.56	7.40	17.71	0.26	34.89	3.97	3.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	241.35	91.97	4.24	6.52	1.30	6.85	2.28	4.24
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	592.58	290.54	57.05	104.36	3.10	64.12	13.71	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	570.09	661.81	90.73	111.93	4.66	60.34	22.47	4.66
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	512.64	433.34	51.47	63.42	3.69	31.52	15.27	4.56
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	530.53	543.16	69.04	91.60	4.84	39.22	20.42	4.57
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	485.79	301.68	37.17	56.74	1.24	18.96	9.66	2.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	466.08	318.80	44.71	72.95	0.83	24.22	6.23	3.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	449.10	312.88	35.58	57.33	0.81	29.07	7.73	3.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	539.19	328.81	49.97	47.69	2.97	17.11	9.36	3.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	517.20	380.55	68.26	69.88	0.62	20.43	8.35	2.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	627.53	391.69	51.80	59.67	0.22	20.33	5.68	3.93
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	572.94	283.96	36.93	39.30	2.36	18.91	7.39	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	425.69	264.98	38.47	49.91	2.86	17.49	7.31	2.23
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	438.80	270.78	38.43	36.42	0.89	16.76	3.57	2.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	726.28	261.32	42.95	35.89	7.46	18.35	10.48	4.64
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	438.52	246.32	33.08	38.17	6.28	16.46	8.31	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	373.58	239.86	38.13	37.86	3.10	17.38	6.30	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	805.39	255.87	32.15	37.98	9.47	26.53	10.61	3.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	669.44	234.65	29.37	35.86	11.27	19.64	13.32	5.12
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	583.03	251.85	35.41	34.86	7.41	16.71	17.48	2.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	499.68	258.49	39.10	42.43	11.90	16.56	8.82	1.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	418.16	240.73	37.57	40.63	15.93	11.64	9.60	2.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	769.31	274.59	33.83	42.71	14.03	17.12	13.82	3.71
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	764.28	332.97	41.51	39.43	19.72	16.72	13.60	3.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	641.38	305.35	32.85	29.68	8.84	12.34	7.50	3.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	898.25	275.54	23.81	30.42	8.60	18.96	8.60	4.85
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	666.49	263.57	26.32	23.37	9.22	19.19	13.65	4.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	612.87	296.47	38.58	37.28	15.72	15.07	9.73	3.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	742.45	228.35	22.77	18.28	2.89	16.36	12.19	3.53
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	781.06	379.78	46.24	41.79	10.23	19.90	13.17	3.03
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	930.71	390.70	41.28	36.22	12.50	13.76	7.75	5.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	851.44	329.02	33.75	26.76	4.56	13.38	12.47	5.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	693.51	349.26	36.69	36.48	8.26	16.31	15.37	3.76
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	894.25	397.83	34.91	35.35	7.68	15.59	6.15	4.39
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	771.23	314.21	31.42	31.14	4.49	16.27	7.57	5.89
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	273.59	252.95	9.54	7.22	0.46	4.17	1.11	1.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	394.42	319.81	16.04	12.03	1.07	5.35	2.41	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	412.96	316.41	10.40	7.96	0.15	2.45	1.84	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	327.60	291.07	13.34	9.07	0.65	2.85	2.59	1.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	384.38	271.62	10.84	7.59	0.27	4.07	2.44	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	439.68	273.58	11.98	6.64	1.66	3.87	2.95	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	455.95	267.12	10.31	7.24	1.10	5.26	3.07	4.61
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	428.43	226.12	7.93	7.93	0.99	3.97	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	380.04	298.91	10.82	6.86	0.26	3.96	2.90	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	421.27	296.99	10.09	7.67	0.20	3.63	1.61	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	401.32	270.43	13.72	9.91	1.27	7.88	2.03	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	342.38	367.66	50.76	81.02	1.39	72.06	21.30	3.58
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	304.15	485.80	49.30	79.04	1.08	48.69	12.17	3.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	324.67	476.47	42.14	70.17	1.64	74.47	20.66	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	353.30	328.26	52.89	68.84	2.19	64.78	25.97	2.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	403.21	354.61	62.73	92.68	3.67	72.33	30.23	5.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	374.04	380.96	41.51	71.03	4.15	79.33	18.45	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	202.93	272.23	34.65	37.12	2.47	61.87	12.37	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	224.74	304.81	30.94	47.58	2.71	41.39	17.02	5.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	316.08	312.87	24.07	52.95	1.60	25.67	12.84	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	246.91	259.09	27.82	41.73	3.48	45.21	17.39	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	248.67	225.88	35.48	44.92	3.58	34.18	15.62	4.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	221.96	219.49	32.53	40.77	3.29	32.12	10.71	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	189.94	143.29	49.98	29.99	6.66	33.32	39.99	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	252.52	178.14	31.32	39.43	2.24	36.35	11.47	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	303.31	220.29	34.65	44.78	3.27	40.86	13.73	3.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	292.75	204.68	37.75	42.78	1.68	31.04	23.49	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	348.61	241.10	48.67	50.57	2.23	34.67	15.90	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	303.66	240.48	41.10	49.93	1.36	33.97	11.21	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	210.90	217.17	37.59	50.12	2.09	20.88	16.71	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	518.87	309.26	66.43	90.49	2.29	45.24	17.18	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	405.79	251.88	50.91	55.05	2.66	42.33	13.02	2.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	276.15	189.74	23.72	28.80	0.00	8.47	30.49	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	342.14	269.23	57.57	43.08	5.38	24.44	15.74	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	321.72	245.09	59.37	61.44	11.97	27.16	16.80	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	242.35	205.47	0.00	52.68	5.27	0.00	10.54	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	306.38	180.67	31.52	44.59	6.15	18.84	9.23	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	293.70	184.17	33.90	40.09	2.93	18.25	8.48	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	380.57	192.63	24.08	30.77	5.35	13.38	9.36	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	400.29	196.10	45.08	52.78	3.08	18.49	9.25	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	384.11	187.94	35.95	38.00	6.16	15.75	10.95	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	183.87	121.75	19.88	27.33	0.00	22.36	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	391.64	175.53	38.69	44.83	3.30	21.23	8.02	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	399.51	185.27	28.36	47.07	0.00	15.69	4.22	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	378.96	160.23	26.96	35.61	2.54	14.24	8.14	6.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	354.57	168.31	39.49	43.87	3.19	17.55	7.18	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	318.71	150.47	35.03	37.00	2.96	16.28	7.89	4.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	272.68	144.01	20.07	38.95	4.72	16.53	3.54	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	338.98	166.87	35.59	47.26	4.67	21.00	5.83	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	312.92	136.93	25.02	34.23	4.83	15.36	7.02	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	295.85	172.08	49.17	38.99	0.85	11.87	3.39	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	335.47	316.96	103.27	45.37	7.16	19.10	14.33	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	345.98	291.63	85.89	65.51	16.98	16.98	11.65	4.37
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	305.87	652.83	47.93	38.80	0.00	22.83	10.27	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	375.07	584.64	27.44	26.20	0.42	16.22	7.48	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	748.89	1251.52	39.36	39.36	1.12	5.62	4.50	12.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	236.60	305.74	14.59	11.42	0.32	5.71	0.95	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	294.09	436.96	30.91	20.05	0.84	9.19	2.92	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	377.83	615.95	165.13	181.37	6.15	37.60	24.02	4.18
Hep-2 cells mock treated, biol_rep2	11899-125E9	309.41	558.56	155.63	182.64	6.08	29.37	19.41	3.21
Hep-2 cells mock treated, biol_rep3	11900-125F1	309.18	557.61	142.64	170.63	5.23	25.03	17.75	3.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	374.05	633.12	172.38	178.06	6.23	34.43	21.53	3.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	339.35	607.99	167.20	180.31	7.52	31.38	24.07	4.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	300.32	502.90	144.45	162.97	4.52	23.04	16.15	2.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	424.05	637.26	177.84	186.18	5.98	42.22	22.67	3.36
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	329.38	521.34	157.83	174.47	6.18	29.85	16.13	3.95
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	312.04	552.32	150.25	175.56	4.81	28.19	18.58	6.73
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	479.60	253.51	5.04	2.24	0.56	2.24	0.00	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	861.26	556.14	28.56	17.31	0.87	4.33	3.46	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	430.94	370.13	18.51	15.86	0.00	0.00	0.00	10.58
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	360.13	382.00	21.16	21.52	0.00	9.52	3.88	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	348.73	423.56	26.15	29.06	2.91	6.54	2.18	3.63
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	344.08	503.01	33.22	30.25	1.22	6.47	6.29	3.15
Hepatocyte, donor1	11523-119I2	95.64	50.85	3.63	6.05	1.21	1.21	1.21	1.21
Hepatocyte, donor2	11603-120I1	102.35	50.63	14.01	25.86	1.08	1.08	1.08	4.31
Hepatocyte, donor3	11684-122I1	138.05	103.69	12.27	13.50	0.61	1.84	1.23	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	122.05	137.72	308.07	263.69	0.00	60.70	15.01	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	199.08	110.99	32.16	25.69	1.22	5.07	5.77	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	460.74	454.43	45.83	50.35	0.69	17.01	15.78	1.51
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	2260.56	990.19	76.41	114.62	6.37	50.94	28.66	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	3050.62	1395.14	80.10	113.48	6.68	46.73	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1570.83	487.50	27.08	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2156.86	946.91	62.30	69.22	2.77	27.69	9.69	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	3103.30	1343.93	117.63	120.13	2.50	22.52	15.02	25.03
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1910.79	913.86	35.60	94.95	0.00	23.74	23.74	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2498.83	1073.86	41.01	79.45	7.69	28.19	7.69	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	3172.11	1448.93	105.13	137.12	4.57	45.71	54.85	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1666.56	851.15	53.60	38.98	1.62	25.99	8.12	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	2147.49	953.70	66.69	91.70	1.67	30.01	13.34	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	2530.50	1150.89	101.66	76.24	3.63	65.35	18.15	18.15
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1609.34	906.58	39.70	58.23	2.65	34.41	3.97	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2041.02	995.56	58.76	90.91	3.33	42.13	18.85	9.98
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	3300.12	1377.67	104.77	110.00	0.00	36.67	41.91	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1170.29	673.95	45.35	46.61	1.26	34.01	10.08	5.04
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	2120.42	1037.78	72.69	68.05	1.55	32.48	20.11	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	2107.40	673.20	73.17	43.90	0.00	0.00	43.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1406.42	836.62	42.64	62.02	0.00	27.13	12.92	5.17
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	2397.18	1085.09	69.23	82.11	3.22	38.64	9.66	9.66
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	3333.55	1242.61	83.64	107.53	0.00	59.74	11.95	47.79
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1346.18	899.63	47.26	51.34	0.81	36.67	8.96	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1985.28	891.68	59.61	68.01	1.68	45.34	11.33	7.98
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	2486.43	847.97	114.98	71.86	0.00	43.12	14.37	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1250.53	720.91	36.97	45.01	1.61	21.70	13.66	5.63
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2081.08	987.91	57.24	67.40	1.85	33.24	13.85	9.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	2171.63	603.23	105.57	45.24	0.00	60.32	30.16	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1215.50	733.55	37.29	39.18	0.47	28.79	13.69	5.66
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1452.08	761.86	56.23	46.26	2.72	24.49	11.79	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	2299.82	648.67	29.48	44.23	0.00	44.23	0.00	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1219.24	832.92	44.12	52.73	1.08	19.37	5.38	8.61
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2166.14	1029.08	54.63	67.33	5.08	45.74	15.25	8.89
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	2365.97	1051.54	98.58	164.30	16.43	65.72	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1449.44	752.46	41.45	48.46	1.28	27.42	8.93	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1844.53	938.67	51.03	58.33	3.65	25.52	9.11	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	1975.55	742.81	31.61	79.02	0.00	15.80	0.00	47.41
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1438.13	816.18	45.70	57.13	1.43	31.42	7.85	7.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	1841.67	895.95	43.14	66.37	0.00	29.86	9.95	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	2209.95	500.37	20.85	83.39	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1028.15	657.14	43.83	41.67	0.93	26.85	10.80	5.25
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	2021.18	960.54	57.95	66.73	3.51	28.10	8.78	8.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	1961.31	908.36	75.44	72.29	0.00	18.86	22.00	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1247.53	712.77	41.72	41.03	1.39	18.08	7.65	9.04
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2334.82	1155.24	53.11	77.46	2.21	24.34	19.92	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	1559.41	842.92	38.90	55.11	3.24	25.94	6.48	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1566.86	817.00	39.24	40.11	0.87	34.88	6.10	6.98
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	1532.10	843.67	58.49	71.99	4.50	31.50	15.75	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	1174.30	623.74	48.78	73.18	3.48	20.91	13.94	17.42
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1272.66	711.54	49.07	51.21	1.07	30.94	8.53	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1361.89	701.03	37.41	49.88	1.39	27.71	4.16	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	1105.65	606.96	25.65	31.35	2.85	31.35	5.70	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1305.16	700.44	37.74	43.26	1.84	25.77	9.20	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	1379.55	650.44	54.46	51.43	0.00	24.20	12.10	12.10
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	1365.91	664.33	49.67	62.09	0.00	24.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1427.45	631.25	30.66	45.47	2.11	28.55	4.23	11.63
Keratinocyte - epidermal, donor1	11272-116H3	578.78	425.38	40.64	36.15	0.33	5.39	1.14	3.02
Keratinocyte - epidermal, donor2	11349-117G8	715.06	556.35	38.07	80.23	0.00	4.10	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	556.39	443.75	55.47	57.17	0.09	3.41	2.75	2.46
Keratinocyte - oral, donor1	11251-116E9	479.50	401.62	43.36	48.36	0.11	7.38	1.70	1.36
Keratocytes, donor1	11527-119I6	393.00	312.20	64.64	77.36	1.38	7.91	1.03	1.03
Keratocytes, donor2	11607-120I5	565.98	437.08	67.96	57.42	1.17	8.20	1.17	2.34
Keratocytes, donor3	11688-122I5	367.53	236.52	35.96	30.83	0.20	4.74	3.95	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	272.54	140.67	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	502.69	486.51	58.25	65.80	1.08	16.18	18.34	1.08
Lens Epithelial Cells, donor2	11609-120I7	569.16	270.80	36.79	34.95	0.23	21.22	14.53	0.46
Lens Epithelial Cells, donor3	11690-122I7	208.58	437.34	22.00	20.99	0.50	11.00	4.44	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	298.81	232.53	7.83	9.84	0.24	1.54	0.59	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	349.12	230.52	7.26	9.21	0.00	3.63	0.84	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	373.07	242.10	7.87	12.44	0.63	2.52	0.94	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	293.59	219.93	8.07	10.22	0.54	0.54	0.54	3.76
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	341.32	232.91	2.84	4.73	0.32	3.15	0.63	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	354.39	248.94	11.21	11.54	0.22	3.13	1.29	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	295.48	203.14	6.98	6.16	0.00	1.23	1.23	2.46
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	435.36	262.93	8.09	7.08	0.25	3.54	0.76	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	350.19	238.15	8.45	10.27	0.14	2.39	1.13	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	283.99	219.92	7.52	8.70	0.00	2.37	0.00	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	375.75	217.34	7.17	7.76	0.19	2.71	0.19	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	404.36	294.57	10.74	11.48	0.00	3.89	0.74	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	315.67	232.75	7.67	9.76	0.35	1.74	0.35	3.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	397.62	243.29	7.63	9.06	0.00	2.39	0.24	2.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	387.32	249.70	9.20	10.44	0.00	2.47	0.96	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	326.13	234.66	7.08	7.08	0.31	1.23	0.62	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	408.70	249.08	9.35	11.85	0.00	1.56	1.87	2.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	413.56	277.05	12.99	13.72	0.00	3.11	1.46	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	330.76	240.91	8.56	8.23	0.00	1.97	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	431.40	248.36	8.79	11.42	0.59	3.51	0.59	2.64
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	480.68	304.94	15.43	14.69	0.25	3.73	1.00	3.98
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	330.75	247.82	11.64	9.21	0.97	3.39	0.97	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	331.50	243.98	9.16	8.35	0.00	2.96	0.81	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	356.19	239.18	8.78	10.14	0.15	2.42	0.45	2.57
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	332.30	227.58	9.33	7.78	0.00	3.11	1.04	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	373.34	233.05	5.44	7.75	0.00	1.47	1.47	2.72
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	373.67	259.39	9.47	11.43	0.15	3.76	1.20	1.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	330.87	260.02	6.88	6.88	0.69	1.38	2.75	4.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	365.95	237.63	8.09	8.47	0.00	4.70	0.75	1.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	371.53	286.39	9.65	12.62	0.00	2.65	0.85	1.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	321.76	226.78	5.33	9.69	0.00	1.94	0.00	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	364.20	231.88	3.31	6.28	0.33	5.95	0.66	3.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	388.28	270.46	12.64	8.55	0.12	3.10	0.62	2.35
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	308.76	232.49	11.85	13.33	0.37	2.59	0.37	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	363.46	229.54	8.65	5.68	0.49	2.47	0.25	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	371.23	254.09	8.39	9.49	0.00	2.34	0.55	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	306.84	222.57	8.36	8.68	0.00	0.96	1.29	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	363.37	223.38	5.17	7.61	0.00	2.13	0.61	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	346.28	251.38	10.08	10.36	0.56	2.38	0.28	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	319.29	232.18	6.76	7.47	0.00	2.13	0.36	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	398.97	263.72	5.82	7.76	0.00	1.94	0.00	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	470.71	321.49	11.83	12.45	0.31	4.82	1.09	2.80
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	333.40	256.05	11.10	11.46	0.36	2.51	1.07	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	369.14	231.94	8.82	4.90	0.00	2.29	0.98	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	427.76	315.94	10.36	15.07	0.00	2.59	1.18	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	298.86	251.34	9.03	10.40	0.12	2.48	0.62	1.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	446.94	266.37	9.99	7.43	0.51	3.59	0.51	2.56
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	345.80	223.17	8.06	8.06	0.00	1.19	2.69	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	990.25	534.78	13.60	15.86	2.27	11.33	2.27	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1692.29	1008.01	32.99	22.25	8.44	13.81	7.67	13.81
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1433.24	800.12	21.52	23.75	6.68	11.88	8.16	12.62
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	1971.36	842.87	33.85	22.85	2.96	16.50	4.65	24.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1731.58	932.61	28.84	26.02	7.03	9.85	9.85	6.33
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1474.73	861.12	26.15	27.09	4.67	13.08	8.41	14.94
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1641.65	741.99	26.79	29.37	4.64	10.82	4.12	32.98
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1903.14	997.96	24.98	14.27	7.14	21.41	3.57	17.84
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1730.83	902.06	26.69	23.75	4.75	16.06	5.43	7.46
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1410.51	679.96	23.85	22.39	4.94	8.72	4.36	10.18
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1436.96	728.83	25.21	18.91	4.95	13.06	5.85	21.61
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	1843.83	913.58	27.64	24.93	5.28	15.31	4.61	9.62
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	2013.53	876.58	30.81	27.22	5.65	13.35	4.62	20.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1489.75	778.40	29.64	23.64	3.18	11.29	8.12	8.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1086.08	615.67	19.99	21.32	7.33	7.33	6.00	5.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	1634.62	743.70	18.34	19.36	2.04	14.26	4.58	20.88
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1390.06	763.33	22.68	23.75	4.27	10.14	3.47	9.61
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1467.91	725.36	21.54	18.89	3.59	10.20	4.53	13.79
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1833.94	795.18	31.29	16.57	4.29	15.34	5.52	18.41
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1944.78	1008.68	29.36	30.99	12.23	13.05	10.60	14.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1452.08	709.28	20.20	19.37	6.04	12.49	2.92	16.66
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1403.55	655.81	25.50	23.54	5.04	14.01	5.61	18.50
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1809.28	867.55	25.76	18.55	2.06	12.36	4.12	20.61
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1511.03	751.31	22.93	19.74	7.26	12.77	2.61	22.35
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1347.28	606.53	18.23	15.54	5.68	9.27	2.99	16.14
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1274.15	679.40	14.94	21.02	6.64	9.41	9.41	13.28
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1892.57	937.09	25.45	27.57	3.89	13.79	4.60	16.26
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1608.62	680.40	26.18	24.34	3.69	13.64	4.06	15.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1793.69	886.48	28.78	28.78	6.91	16.12	4.61	18.42
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1882.31	935.21	26.10	24.18	8.44	13.05	4.99	13.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	1692.73	793.72	26.61	15.29	4.53	8.49	4.53	24.91
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1742.67	904.98	22.97	18.05	6.56	13.95	8.20	12.31
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1893.84	906.93	30.28	21.24	6.33	11.75	4.97	13.56
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1776.69	782.06	29.44	24.42	5.75	9.34	5.75	17.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1868.01	978.44	19.42	19.42	5.23	11.95	11.95	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1804.08	946.08	26.01	19.32	6.69	13.01	3.34	15.98
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1570.50	743.90	23.69	20.68	3.45	12.49	4.31	12.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	1759.69	989.02	19.69	21.41	7.71	7.71	8.56	10.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1948.42	963.88	28.99	22.99	6.66	14.66	7.66	14.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1747.78	822.31	25.94	18.70	6.64	10.86	10.26	12.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	1936.76	1005.35	24.88	26.31	9.24	10.66	10.66	9.95
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1859.51	931.13	29.90	26.12	7.22	9.97	6.19	16.84
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1698.27	802.44	24.15	25.23	8.59	17.18	3.22	15.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	1811.34	1012.73	29.63	25.59	8.08	12.79	8.08	11.45
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1980.57	925.65	25.56	21.11	6.30	8.89	7.04	20.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1000.12	527.97	17.44	23.26	9.30	12.79	6.98	20.93
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1854.22	966.78	19.04	24.33	7.40	14.81	6.35	10.58
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	2055.58	936.75	25.21	24.01	4.00	10.80	4.80	18.01
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	1679.08	777.75	26.17	26.89	8.72	15.99	6.54	14.54
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	2051.97	1181.97	48.29	19.16	2.30	12.26	7.67	18.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1968.18	937.23	27.62	25.16	5.43	13.32	3.45	20.22
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1645.69	733.93	20.70	20.70	8.47	10.35	2.82	13.17
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	2162.13	1072.52	22.12	21.62	5.53	13.58	9.05	17.10
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1867.39	900.35	25.23	18.48	7.66	17.12	4.51	21.63
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1438.84	619.60	24.10	17.21	6.88	24.10	1.72	37.86
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1900.72	1021.62	27.17	23.60	4.45	10.69	8.46	16.48
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1794.42	856.35	25.42	26.59	6.65	10.17	4.69	11.73
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1560.27	755.40	22.43	25.07	12.53	17.15	5.28	15.83
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1802.23	958.46	23.35	21.28	8.82	16.61	7.26	19.20
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	1655.31	875.13	34.57	20.13	2.63	10.94	2.63	21.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1535.85	687.69	20.13	16.21	4.47	10.62	4.47	18.45
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1622.59	897.86	26.94	21.20	5.30	9.27	5.30	11.92
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1728.78	866.70	21.60	18.90	7.71	12.73	3.86	17.74
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1547.93	675.48	19.75	17.72	9.62	10.13	2.03	18.23
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1798.48	931.92	22.59	28.84	2.40	9.13	6.25	18.74
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1812.41	831.27	24.25	22.66	5.57	8.75	2.78	22.26
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1665.49	614.91	25.52	17.01	7.29	13.98	2.43	20.05
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1837.16	600.40	27.67	17.29	8.30	12.45	10.38	17.29
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1876.77	844.34	27.74	20.14	7.22	13.30	6.46	15.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1593.15	675.99	29.95	26.85	7.75	14.98	4.13	21.17
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	2216.06	697.17	36.88	18.74	4.84	15.72	7.26	10.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1772.11	835.35	25.04	14.89	6.34	10.46	6.02	20.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1684.03	679.16	32.52	20.79	4.26	13.33	4.26	15.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2255.58	688.46	41.38	20.11	1.72	22.99	9.77	16.09
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1899.58	874.71	26.23	25.71	4.11	11.31	2.57	21.08
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	1753.53	725.04	26.88	22.64	7.07	14.15	2.12	16.98
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2193.90	800.72	39.16	22.70	5.67	22.13	6.81	17.59
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1990.26	915.67	21.63	19.14	7.90	12.06	2.50	21.22
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	1864.42	814.36	34.45	29.76	7.83	13.31	7.05	28.19
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2212.58	810.88	32.99	25.47	6.68	15.45	10.86	12.53
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1928.25	951.58	27.88	22.77	3.72	9.76	5.11	19.51
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	2009.82	830.29	28.77	22.75	9.37	16.73	6.02	18.73
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2454.01	834.04	41.17	31.01	9.62	21.39	13.37	24.06
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1867.73	974.27	32.73	29.90	4.45	13.74	5.66	13.34
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1781.38	822.31	28.45	23.86	6.42	13.77	2.75	19.27
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2334.80	830.43	39.12	32.90	1.78	27.56	8.89	22.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	2102.82	955.10	31.34	31.91	7.41	11.97	3.99	11.40
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1903.44	876.57	32.21	22.24	5.37	16.87	3.07	17.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	2548.75	755.65	38.85	39.94	5.47	23.53	8.21	14.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1973.78	981.32	25.39	24.95	7.13	11.14	4.90	14.25
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2064.56	1036.18	36.91	29.11	5.72	11.18	6.76	11.18
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2789.03	864.03	49.07	35.81	9.28	21.88	9.95	13.93
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	2785.34	1006.05	20.79	35.34	14.55	18.71	8.31	18.71
Macrophage - monocyte derived, donor1	11232-116C8	419.14	391.33	82.51	59.26	0.00	20.51	7.29	4.56
Macrophage - monocyte derived, donor2	11313-117C8	545.57	484.83	44.96	39.45	0.18	11.01	6.24	2.75
Macrophage - monocyte derived, donor3	11389-118C3	571.64	583.84	60.30	50.34	0.52	19.40	4.98	5.37
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	409.42	282.50	8.50	15.93	0.53	0.53	0.53	1.59
Mallassez-derived cells, donor2	11929-125I3	264.93	229.76	9.19	11.73	0.48	0.79	0.32	1.43
Mallassez-derived cells, donor3	11930-125I4	498.27	291.73	28.49	30.72	0.14	2.64	1.81	2.36
Mammary Epithelial Cell, donor1	11273-116H4	606.13	446.80	13.15	13.25	0.90	2.39	0.70	0.70
Mammary Epithelial Cell, donor2	11350-117G9	519.74	512.21	28.95	31.56	0.29	1.16	1.16	0.58
Mammary Epithelial Cell, donor3	11422-118F9	1389.81	1015.17	13.72	13.97	0.75	4.49	1.50	5.49
Mast cell - stimulated, donor1	11487-119E2	144.40	154.57	63.73	47.46	0.00	19.66	2.71	0.68
Mast cell, donor1	11563-120D6	224.50	263.54	80.13	53.96	0.11	28.22	7.03	3.57
Mast cell, donor2	11565-120D8	133.13	201.19	37.74	47.55	0.00	11.89	2.67	5.65
Mast cell, donor3	11566-120D9	103.33	198.78	30.84	47.50	0.00	10.58	2.25	7.20
Mast cell, donor4	11567-120E1	135.45	191.65	35.99	56.02	0.18	14.18	5.85	6.91
Mast cell, expanded and stimulated, donor5	11940-126A5	205.37	204.04	90.38	75.52	0.11	16.30	4.55	1.77
Mast cell, expanded and stimulated, donor8	11942-126A7	249.23	154.09	69.46	54.28	0.00	18.68	2.92	5.25
Mast cell, expanded, donor5	11939-126A4	201.45	264.78	84.78	78.47	0.34	26.96	6.08	5.97
Mast cell, expanded, donor8	11941-126A6	155.48	194.31	72.97	46.70	0.17	17.57	5.02	6.03
Melanocyte - dark, donor1	11502-119F8	327.45	245.36	9.55	17.51	0.30	1.89	0.40	0.90
Melanocyte - dark, donor2	11582-120F7	413.22	380.00	28.03	18.69	1.04	7.61	5.54	1.73
Melanocyte - dark, donor3	11663-122F7	421.03	396.32	29.05	25.43	0.22	5.87	2.10	1.23
Melanocyte - light, donor1	11274-116H5	388.34	388.57	39.02	28.44	0.24	10.58	4.70	2.12
Melanocyte - light, donor2	11351-117H1	583.51	657.90	46.41	43.00	0.00	8.19	5.46	12.28
Melanocyte - light, donor3	11423-118G1	594.05	522.07	44.23	26.02	2.60	4.34	0.87	8.67
Melanocyte, donor1 (MC+1)	12641-134G4	518.13	278.85	40.30	35.40	0.42	8.54	6.77	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	314.93	284.54	36.31	25.82	0.00	9.41	2.69	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	440.62	178.66	16.34	10.71	0.27	3.75	1.07	3.75
Meningeal Cells, donor1	11493-119E8	346.00	303.20	22.58	22.83	0.99	11.17	3.85	1.12
Meningeal Cells, donor2	11573-120E7	455.55	294.90	37.41	26.41	2.20	15.85	7.48	1.76
Meningeal Cells, donor3	11654-122E7	383.30	387.70	25.10	21.11	1.63	13.61	7.25	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	348.46	326.22	49.33	33.08	0.86	7.13	6.27	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	181.84	333.90	26.97	11.77	1.01	4.63	3.42	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1350.96	1036.88	38.11	28.91	1.31	14.46	2.63	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	733.88	596.52	90.26	62.79	5.23	17.01	6.54	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	484.38	456.40	16.50	17.22	0.72	2.15	2.87	3.59
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	168.36	358.95	16.52	10.80	1.69	3.39	2.54	2.33
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	279.97	446.35	26.64	19.10	2.01	4.02	3.02	6.03
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	398.63	453.13	54.28	49.44	2.64	6.81	6.15	1.32
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	398.17	420.09	68.68	67.21	4.38	3.65	6.58	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	480.20	474.88	59.54	47.67	2.25	5.73	3.89	2.86
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	584.50	623.84	58.17	31.30	1.66	12.47	3.05	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	269.13	390.68	34.57	25.65	2.23	9.66	2.60	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	575.90	645.50	48.81	25.00	1.45	13.82	5.79	1.84
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	238.58	321.37	26.11	14.84	1.48	6.23	2.37	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	296.61	415.73	44.38	23.36	2.34	9.34	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	477.74	540.50	60.84	64.68	1.28	10.25	8.97	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	377.48	389.18	21.27	18.43	0.35	3.90	2.48	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	582.60	688.93	52.54	29.40	2.19	11.57	14.07	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	336.00	530.48	71.84	56.60	3.63	10.89	14.51	1.45
Mesothelial Cells, donor1	11247-116E5	350.56	435.68	29.70	33.41	2.39	9.81	10.87	0.80
Mesothelial Cells, donor2	12156-128G5	285.77	458.43	39.54	23.02	1.00	7.01	5.51	2.50
Mesothelial Cells, donor3	11402-118D7	396.80	381.41	22.62	17.05	0.51	4.05	2.75	1.66
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	278.17	275.47	9.45	4.05	0.00	6.75	5.40	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	482.45	321.88	35.71	29.06	0.25	16.50	7.88	5.17
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	699.34	355.71	18.85	15.90	0.29	7.66	4.12	3.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	318.05	238.54	10.37	3.46	3.46	0.00	0.00	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	379.99	253.23	34.09	24.18	0.31	9.61	6.82	3.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	597.41	317.79	20.74	20.54	0.62	9.33	4.56	1.87
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	326.56	236.24	2.32	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	564.09	298.56	44.30	34.29	0.25	11.51	7.51	4.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	595.81	267.19	11.17	13.50	0.93	7.91	2.79	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	291.99	97.33	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	537.30	295.48	36.38	27.23	0.41	9.55	7.52	4.06
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	612.55	310.83	21.38	11.48	0.40	9.11	2.38	3.17
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	393.37	136.82	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	439.81	298.22	39.82	40.71	0.88	13.27	9.73	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	747.34	401.21	28.12	25.08	0.00	12.54	2.66	3.80
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	248.71	140.80	3.95	0.00	0.00	2.63	2.63	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	433.15	287.14	32.89	33.11	0.21	9.97	8.06	2.33
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	416.21	168.51	5.52	5.52	0.92	2.76	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	215.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	388.37	222.65	20.57	18.78	0.00	7.75	6.56	3.58
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	491.27	154.25	1.68	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	237.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	423.52	256.67	30.36	26.60	0.50	8.53	6.52	2.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	529.52	251.69	21.39	15.21	0.24	7.84	3.57	2.85
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	200.70	186.32	4.42	2.21	0.00	6.08	0.00	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	363.10	254.42	34.08	27.40	0.46	6.91	5.76	4.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	542.25	281.01	16.41	13.25	0.21	6.10	3.58	2.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	380.55	253.97	28.13	24.66	0.20	7.13	2.85	3.67
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	372.01	260.45	38.19	25.10	0.64	8.15	6.65	3.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	495.26	228.74	12.67	12.23	0.22	6.89	2.22	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	227.01	72.23	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	336.19	197.77	26.50	20.37	0.88	8.54	3.72	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	396.44	187.57	8.62	7.60	1.01	2.03	3.04	3.55
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	304.89	159.07	3.31	0.00	0.00	3.31	1.66	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	297.88	181.56	15.49	15.49	0.27	3.81	3.26	2.72
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	503.47	230.27	9.70	12.35	0.00	5.88	1.18	3.53
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	287.85	155.92	3.27	1.09	1.09	1.09	1.09	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	512.75	328.22	42.29	33.16	1.44	10.09	5.29	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	567.93	254.15	15.21	13.21	0.00	7.60	2.40	7.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	553.97	190.60	4.11	6.86	0.00	0.00	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	572.16	340.89	28.53	31.54	1.00	9.01	4.00	5.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	700.63	296.42	26.95	26.95	0.00	0.00	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	462.74	159.00	8.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	510.62	239.98	34.16	28.03	0.44	5.69	3.07	3.94
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	437.05	121.40	3.31	4.41	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	548.81	179.31	5.12	1.28	0.00	1.28	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	532.53	285.60	33.72	29.50	0.50	8.43	4.46	2.48
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	430.06	146.14	2.78	4.87	0.70	2.78	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	506.06	194.47	8.84	15.47	0.00	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	592.13	322.39	48.20	47.18	1.37	9.91	7.52	4.79
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	517.70	156.67	2.63	5.25	0.88	2.63	0.88	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	521.64	223.00	6.75	9.94	0.36	1.78	2.49	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	575.13	333.01	69.86	46.01	0.56	8.70	4.77	3.09
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	440.15	187.86	5.40	3.33	0.00	2.08	1.25	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	645.10	236.59	8.74	7.58	0.58	3.50	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	564.72	330.93	37.71	34.09	0.00	6.64	3.62	8.45
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	582.68	258.37	12.10	16.70	1.25	5.43	3.34	5.84
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	534.19	180.47	7.22	0.00	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	416.52	232.74	36.94	28.63	0.00	3.69	4.62	4.62
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	737.01	221.39	10.24	8.54	0.00	3.41	3.41	7.40
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	485.85	304.55	33.03	25.84	0.14	8.29	6.63	2.63
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	550.95	347.00	72.04	52.61	0.26	12.44	3.63	4.66
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	742.13	226.93	11.58	9.44	0.86	3.43	2.57	5.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	551.98	226.76	6.35	9.53	0.00	2.54	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	406.21	252.48	29.36	24.29	0.27	5.87	2.40	3.74
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	620.81	326.57	22.45	24.25	0.00	7.48	3.59	2.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	419.81	316.27	35.03	28.11	0.00	10.31	4.66	1.55
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	597.21	404.51	90.14	74.53	0.64	12.42	6.69	3.19
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	685.51	268.67	14.59	12.16	0.44	6.19	3.32	3.98
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	502.06	295.40	17.06	11.76	0.38	6.45	3.03	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	483.83	389.79	69.04	56.25	0.28	12.50	7.67	4.55
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	810.91	381.24	26.55	27.28	0.74	9.09	4.42	5.90
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	669.27	324.53	10.43	7.17	0.00	2.61	1.30	3.91
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	405.17	329.90	52.34	34.70	0.00	9.70	5.59	2.35
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	759.45	376.27	27.39	28.54	0.00	10.96	5.77	3.46
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	370.52	317.76	30.09	28.85	0.00	14.84	2.89	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	399.03	341.85	45.56	34.25	0.89	11.02	6.25	2.08
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	233.55	188.34	71.57	41.44	0.00	7.53	3.77	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	245.95	176.44	48.12	55.25	0.00	10.69	5.35	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	437.00	260.56	91.34	78.20	0.00	26.61	12.16	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	532.29	347.14	83.10	66.27	2.10	15.78	4.21	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	338.64	196.90	32.42	33.80	0.59	13.24	5.14	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	327.83	195.58	16.76	15.83	0.00	8.38	7.45	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	278.64	181.38	30.79	28.54	0.75	12.39	5.26	3.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	588.62	400.05	37.29	32.49	0.27	11.45	6.92	2.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	287.62	203.81	63.34	57.68	0.23	15.16	5.20	1.58
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	372.78	229.12	53.78	56.73	0.00	11.05	7.37	6.63
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	356.90	205.56	61.56	70.35	0.00	12.09	6.96	5.50
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	423.12	325.12	60.67	52.89	0.00	14.00	7.78	10.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	201.48	145.90	39.01	29.39	0.53	5.88	3.74	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	243.43	197.06	46.37	19.32	0.00	0.00	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	390.85	231.28	59.59	62.62	0.00	21.21	6.06	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	333.10	226.84	24.46	25.72	0.42	8.85	2.53	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	100.78	76.27	13.62	12.26	0.00	2.72	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	88.38	68.03	20.35	10.17	0.00	3.81	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	71.27	45.35	12.15	4.86	0.00	2.43	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	129.90	74.01	9.06	16.61	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	251.25	74.23	0.00	0.00	0.00	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	117.45	52.20	6.52	16.31	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	218.61	118.81	4.75	0.00	0.00	0.00	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	250.98	62.75	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	217.16	532.34	43.95	34.47	5.39	13.14	11.85	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	301.55	415.48	38.67	31.36	1.57	21.43	8.88	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	278.34	264.33	26.70	28.03	2.67	4.00	2.67	4.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	202.01	215.36	14.61	10.85	0.42	2.92	4.59	4.17
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	360.70	304.80	45.44	29.47	0.00	7.42	10.27	4.75
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	410.13	258.53	23.94	19.15	0.00	7.98	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	217.58	172.03	19.72	17.00	0.00	3.40	2.72	4.76
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	62.48	123.12	7.35	9.19	0.00	1.84	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	202.99	172.85	25.11	17.16	0.84	2.93	3.35	2.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	224.77	302.87	22.08	16.27	0.70	6.74	6.97	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	195.64	156.73	26.21	21.89	0.81	4.59	3.51	4.05
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	259.01	225.16	24.18	18.71	0.84	5.26	2.94	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	189.29	55.67	22.27	0.00	11.13	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	256.12	262.08	32.76	23.33	0.50	7.45	5.96	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	218.97	191.36	36.27	12.18	0.00	6.50	4.06	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	188.83	223.73	25.62	13.60	0.68	9.52	7.71	4.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	261.61	166.40	21.72	15.84	0.82	6.21	2.45	3.43
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	217.61	190.82	30.62	19.87	0.73	6.93	6.56	3.10
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	254.61	208.46	22.81	20.69	1.59	5.30	6.90	5.30
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	262.33	172.29	18.61	17.41	0.00	5.40	3.00	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	251.38	170.00	29.86	11.81	0.00	7.22	2.30	2.63
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	195.96	193.36	15.12	10.41	0.33	5.20	4.07	2.28
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	202.49	188.55	27.87	18.87	0.18	5.82	4.76	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	185.65	183.54	39.38	16.88	1.41	7.74	1.41	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	228.94	191.70	18.85	12.87	0.00	5.98	1.84	5.06
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	166.46	163.89	25.39	20.57	0.00	3.86	4.82	4.18
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	214.52	254.87	29.32	11.38	0.34	7.24	9.31	6.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	101.14	144.12	22.76	20.23	0.00	5.06	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	193.60	181.79	29.41	16.04	0.67	4.23	2.01	2.01
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	201.11	202.38	36.84	16.51	0.85	5.93	7.20	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	235.22	153.80	23.02	6.65	0.00	4.75	2.61	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	177.71	193.59	38.63	28.33	0.86	5.15	6.01	5.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	81.25	27.08	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	179.27	133.62	23.33	13.66	0.67	5.00	3.67	3.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	223.18	172.68	23.44	13.53	0.90	4.96	2.25	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	186.89	165.86	39.68	21.03	0.40	7.54	6.35	3.17
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	247.02	183.87	31.57	18.57	2.79	10.22	0.93	4.64
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	153.24	173.67	31.40	20.81	0.38	4.54	6.05	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	171.09	219.65	14.01	12.71	0.33	7.50	3.91	2.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	191.75	98.49	10.89	10.46	0.44	4.36	2.61	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	170.06	171.87	20.81	14.02	0.00	6.78	2.26	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	161.39	205.48	38.80	20.28	1.76	6.17	3.53	6.17
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	257.30	198.79	37.23	19.28	1.33	6.65	5.32	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	197.43	149.81	31.75	22.32	1.98	4.46	2.98	3.97
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	175.72	191.03	16.84	9.19	0.38	3.45	1.53	4.59
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	205.06	168.76	44.46	19.05	0.00	5.75	7.86	3.63
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	176.82	195.16	29.18	18.34	0.44	5.75	3.09	2.43
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	213.46	222.27	32.53	10.16	0.68	7.45	6.78	5.42
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	137.96	25.55	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	183.51	139.62	26.83	18.29	0.00	6.10	4.88	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	149.18	137.54	14.48	6.29	0.31	3.46	4.09	1.89
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	188.25	86.56	16.34	13.92	0.00	4.24	4.54	2.12
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	160.60	135.28	22.15	11.87	0.79	5.54	3.16	5.54
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	231.26	205.19	35.14	10.20	0.00	10.20	4.53	10.20
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	91.04	40.46	10.12	0.00	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	275.41	664.37	60.13	40.50	1.49	8.94	6.09	5.59
Myoblast, donor2	11322-117D8	318.18	525.50	70.39	53.13	0.77	9.21	5.37	4.60
Myoblast, donor3	11398-118D3	285.54	539.80	62.72	40.70	1.35	11.27	7.57	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	332.87	207.37	519.67	212.19	0.29	12.11	6.42	2.04
Natural Killer Cells, donor1	11230-116C6	73.19	160.22	49.20	34.75	0.00	12.30	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	80.21	234.01	40.11	29.85	0.00	14.17	1.21	0.90
Natural Killer Cells, donor3	11387-118C1	102.89	190.31	49.14	30.55	0.00	9.02	1.29	1.29
Neural stem cells, donor1	11275-116H6	175.30	170.58	14.88	15.97	0.73	12.34	7.26	0.73
Neural stem cells, donor2	11352-117H2	71.25	163.68	5.78	11.55	0.00	7.70	1.93	0.00
Neurons, donor1	11494-119E9	282.20	252.61	3.41	19.34	0.00	9.10	7.97	1.14
Neurons, donor2	11574-120E8	174.81	187.80	9.91	20.92	0.00	17.39	5.72	1.32
Neurons, donor3	11655-122E8	326.40	222.81	8.22	11.51	0.00	9.04	9.04	2.47
Neutrophils, donor1	11233-116C9	532.67	320.16	1.86	0.00	0.00	0.00	0.00	3.71
Neutrophils, donor2	11314-117C9	684.14	408.74	2.90	0.00	0.00	0.00	0.00	11.60
Neutrophils, donor3	11390-118C4	648.71	323.75	0.61	0.61	0.00	0.00	0.00	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	492.63	290.07	24.10	19.95	0.71	9.26	4.63	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	453.57	322.67	20.19	25.40	0.65	8.79	0.65	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	449.24	368.01	63.58	51.94	1.40	12.84	9.43	1.40
Olfactory epithelial cells, donor1	11933-125I7	523.63	616.40	47.49	31.80	0.83	16.66	9.50	3.99
Olfactory epithelial cells, donor2	11934-125I8	381.26	614.44	60.50	34.74	1.45	17.22	8.97	3.76
Olfactory epithelial cells, donor3	11935-125I9	273.77	402.94	32.92	25.54	0.34	11.92	2.95	1.02
Olfactory epithelial cells, donor4	11936-126A1	670.48	612.34	60.68	40.13	1.07	19.87	9.35	3.90
Oligodendrocyte - precursors, donor1	11496-119F2	349.66	281.05	66.20	51.76	0.00	8.43	8.43	0.00
Osteoblast - differentiated, donor1	11276-116H7	460.48	1001.36	67.21	34.46	1.28	14.89	9.15	7.23
Osteoblast - differentiated, donor2	11353-117H3	155.46	441.24	26.29	17.15	0.00	2.29	5.72	22.86
Osteoblast - differentiated, donor3	11425-118G3	292.35	325.87	26.07	20.48	0.00	5.59	0.62	6.21
Osteoblast, donor1	11277-116H8	539.02	701.03	85.99	84.23	0.59	13.88	7.23	3.71
Osteoblast, donor2	11354-117H4	257.05	514.10	60.40	42.84	0.70	4.92	4.92	1.40
Osteoblast, donor3	11426-118G4	657.60	1080.60	89.04	59.90	1.24	11.55	7.82	7.82
Pancreatic stromal cells, donor1	11249-116E7	228.28	295.58	16.26	10.87	1.52	2.53	1.26	2.44
Pericytes, donor1	11491-119E6	499.36	564.45	70.99	55.74	3.00	58.97	33.71	3.12
Pericytes, donor2	11571-120E5	494.84	406.33	83.98	52.29	4.07	22.18	12.45	2.72
Pericytes, donor3	11652-122E5	1556.80	1095.37	71.61	41.30	3.87	20.14	12.61	10.99
Perineurial Cells, donor1	11499-119F5	528.94	535.49	39.33	39.11	0.79	17.29	12.55	2.03
Perineurial Cells, donor2	11579-120F4	349.46	317.16	20.98	16.38	0.46	7.82	5.34	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	225.03	168.29	34.42	40.16	0.00	14.02	0.96	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	288.45	194.18	38.20	36.24	0.00	12.49	1.96	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	241.23	207.58	35.07	32.35	0.00	10.22	1.16	1.55
Placental Epithelial Cells, donor1	11278-116H9	577.11	220.75	52.86	34.44	0.24	5.50	1.91	1.67
Placental Epithelial Cells, donor2	11355-117H5	520.07	380.35	21.07	21.07	2.22	5.54	2.22	4.44
Placental Epithelial Cells, donor3	11427-118G5	520.27	253.46	19.63	16.88	0.39	5.69	0.98	2.75
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	265.19	332.27	20.89	12.97	0.00	3.16	4.75	8.54
Preadipocyte - breast, donor1	11467-119B9	266.19	326.59	19.51	10.69	0.94	5.25	1.69	3.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	302.17	647.81	33.81	23.63	0.65	8.61	9.01	1.44
Preadipocyte - breast, donor2	11328-117E5	285.49	500.73	19.59	11.48	0.45	6.08	2.93	3.38
Preadipocyte - omental, donor1	11468-119C1	367.95	391.18	16.94	8.21	0.85	6.07	3.73	5.86
Preadipocyte - omental, donor2	11329-117E6	230.46	408.54	11.35	9.17	0.44	1.31	2.62	5.24
Preadipocyte - omental, donor3	11403-118D8	322.17	528.59	15.04	10.46	0.86	4.87	1.00	4.73
Preadipocyte - perirenal, donor1	11469-119C2	587.61	567.92	52.17	27.56	2.95	8.86	9.84	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	572.16	1224.48	50.67	41.46	3.07	7.37	3.99	4.30
Preadipocyte - subcutaneous, donor2	11356-117H6	335.03	479.70	31.17	26.38	1.42	4.07	3.19	1.95
Preadipocyte - subcutaneous, donor3	11428-118G6	401.87	656.28	44.44	28.61	1.53	5.28	3.41	3.92
Preadipocyte - visceral, donor1	11280-116I2	254.57	338.59	36.79	32.32	0.65	5.78	2.89	1.49
Preadipocyte - visceral, donor2	11357-117H7	296.82	362.16	35.43	32.67	0.92	6.90	1.38	1.84
Preadipocyte - visceral, donor3	11429-118G7	375.64	392.47	32.91	28.42	0.84	6.06	4.18	2.82
Prostate Epithelial Cells (polarized), donor1	11253-116F2	203.05	117.66	35.75	29.27	1.66	3.92	2.11	3.92
Prostate Epithelial Cells, donor2	11331-117E8	848.91	636.71	38.05	29.52	2.84	4.33	2.71	18.28
Prostate Epithelial Cells, donor3	11404-118D9	254.87	101.23	20.88	17.58	0.12	1.35	0.24	5.76
Prostate Stromal Cells, donor1	11254-116F3	249.78	472.80	55.13	36.11	3.99	9.57	4.10	3.99
Prostate Stromal Cells, donor2	11332-117E9	398.04	614.99	41.24	26.18	3.77	3.59	2.51	3.41
Prostate Stromal Cells, donor3	11405-118E1	333.27	606.05	26.59	17.10	1.88	4.90	1.88	7.20
Renal Cortical Epithelial Cells, donor1	11516-119H4	477.03	305.13	27.01	46.72	0.00	5.84	1.82	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	990.05	341.78	23.70	29.11	0.28	5.06	2.22	2.63
Renal Epithelial Cells, donor1	11517-119H5	741.57	518.90	42.10	73.04	0.00	13.19	2.03	1.52
Renal Epithelial Cells, donor2	11597-120H4	449.55	377.71	30.59	37.70	0.00	7.11	7.82	3.56
Renal Epithelial Cells, donor3	11678-122H4	686.11	321.30	17.68	24.35	0.32	4.45	1.59	1.80
Renal Glomerular Endothelial Cells, donor1	11514-119H2	511.32	300.26	9.53	13.62	0.68	1.36	1.36	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	550.11	304.57	18.46	13.75	0.27	2.83	2.16	3.10
Renal Glomerular Endothelial Cells, donor3	11675-122H1	360.77	326.13	15.10	19.76	0.44	2.44	2.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	364.00	295.46	7.32	14.64	0.67	0.00	2.00	3.33
Renal Mesangial Cells, donor1	11518-119H6	375.91	337.84	22.01	34.77	1.98	5.72	4.18	0.66
Renal Mesangial Cells, donor2	11598-120H5	420.71	326.03	29.47	29.47	0.00	5.64	2.51	4.39
Renal Mesangial Cells, donor3	11679-122H5	526.25	337.61	21.92	21.64	0.55	4.99	3.33	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	703.54	326.94	27.92	53.15	0.00	4.29	1.07	2.95
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	750.61	297.71	30.78	42.59	0.84	2.53	1.27	4.64
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	544.41	320.51	32.01	45.13	0.58	4.63	3.66	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1282.67	427.04	60.93	59.89	1.81	20.22	21.52	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	335.98	224.84	13.93	17.05	0.57	9.38	3.70	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	699.80	385.92	28.82	31.90	1.03	12.35	3.09	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	343.49	152.80	10.54	8.53	0.25	13.55	6.27	2.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	202.59	112.65	12.70	10.96	0.27	5.88	2.27	1.74
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	252.83	95.59	35.74	16.08	0.00	13.40	16.08	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	251.52	157.96	67.15	32.47	0.55	13.76	23.12	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	259.86	147.33	58.59	17.40	0.58	11.02	14.50	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	203.62	187.76	50.58	29.78	1.17	17.16	10.92	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	335.35	351.64	69.61	37.84	0.50	22.94	20.95	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	254.98	302.38	67.48	41.16	1.12	18.40	13.16	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	305.77	295.35	91.30	51.35	0.99	20.84	14.26	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	374.11	392.29	91.14	45.10	0.82	22.14	13.64	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	316.19	317.34	67.03	43.45	0.69	14.10	11.79	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	340.35	245.75	68.32	41.21	0.14	20.54	21.08	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	320.40	317.67	74.73	34.94	0.61	17.55	17.09	2.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	244.24	287.78	58.42	37.63	0.18	15.05	12.01	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	371.41	294.09	84.93	56.38	0.86	20.51	19.08	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	343.84	380.86	79.52	46.04	0.64	19.21	14.92	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	304.02	356.47	73.46	44.92	0.22	19.69	19.25	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	312.19	246.04	61.94	38.24	1.15	17.01	13.38	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	322.62	333.24	54.50	27.95	0.37	17.24	15.09	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	199.93	239.96	55.62	32.32	0.00	19.54	10.90	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	379.94	261.17	45.92	31.05	0.93	15.92	14.73	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	295.62	322.39	63.76	33.29	0.39	15.77	17.03	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	294.84	344.49	67.22	33.04	0.00	18.52	21.20	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	360.96	264.21	55.75	38.13	0.32	20.61	15.81	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	303.01	318.43	61.95	33.92	0.56	19.34	12.89	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	249.68	285.57	50.24	26.15	0.51	16.75	8.72	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	373.23	255.44	53.79	29.72	1.28	16.41	14.22	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	349.38	376.11	69.16	35.56	0.98	18.89	13.86	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	299.13	332.31	68.10	39.49	0.27	20.15	15.58	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	355.22	273.14	102.13	61.80	1.65	26.65	18.63	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	363.10	363.69	74.41	38.49	0.60	18.25	11.31	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	293.24	337.44	65.94	37.65	0.23	15.43	15.67	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	358.93	285.32	88.33	56.19	0.62	24.88	24.26	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	297.75	330.27	60.17	38.27	0.22	18.14	11.72	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	270.71	299.96	55.35	28.83	1.04	15.88	11.28	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	355.03	294.20	74.29	45.49	0.94	24.09	21.00	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	320.15	343.48	40.53	22.31	0.68	15.50	14.30	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	291.70	317.34	50.71	34.70	0.19	14.65	11.95	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	301.75	291.61	85.80	54.50	0.86	18.40	16.68	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	320.56	352.25	38.96	17.97	0.14	13.03	11.66	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	261.52	318.32	45.80	32.01	0.99	16.09	6.73	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	255.65	200.26	43.97	30.51	1.36	13.63	10.40	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	209.95	302.43	52.67	29.15	0.59	13.91	17.75	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	197.25	269.48	39.98	23.46	0.80	10.66	5.06	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	226.20	101.21	31.25	19.36	0.55	16.45	10.51	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	270.01	246.44	50.95	28.33	0.00	19.29	16.67	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	285.38	251.93	70.54	35.27	0.60	14.91	10.68	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	317.56	230.35	100.67	51.42	0.66	25.14	20.44	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	190.05	158.96	46.47	24.11	0.00	18.17	11.53	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	119.07	111.52	29.62	15.11	0.00	9.37	7.56	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	441.45	307.44	164.00	83.35	0.98	27.66	22.40	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	130.27	119.94	38.86	19.21	0.29	10.48	5.09	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	234.85	203.82	76.66	34.07	0.61	14.60	14.60	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	439.74	299.59	161.55	78.97	1.21	23.81	18.69	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	252.88	187.51	66.27	38.90	0.45	13.80	14.93	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	281.87	241.43	69.79	34.75	0.30	10.48	9.88	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	113.23	99.18	43.22	26.80	0.35	13.34	8.27	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	191.46	171.18	63.18	33.94	0.21	13.02	11.10	6.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	191.11	179.09	58.29	34.86	0.60	7.81	8.41	3.00
Schwann Cells, donor1	11498-119F4	586.78	407.36	31.22	33.29	0.94	15.42	7.90	3.57
Schwann Cells, donor2	11578-120F3	306.22	319.83	34.02	27.22	0.00	6.80	6.80	0.00
Schwann Cells, donor3	11659-122F3	349.22	458.10	12.93	13.80	0.44	5.92	2.41	3.07
Sebocyte, donor1	11220-116B5	331.40	271.69	20.27	18.62	0.00	2.19	2.19	0.55
Sebocyte, donor2	11301-117B5	383.73	286.30	26.65	36.76	0.00	3.22	0.92	1.84
Sebocyte, donor3	11378-118B1	311.64	329.16	51.73	42.67	0.00	5.57	1.44	1.24
Sertoli Cells, donor1	11255-116F4	674.24	874.68	67.92	24.85	0.00	9.94	1.66	9.94
Sertoli Cells, donor2	11333-117F1	844.49	703.27	45.19	48.01	2.82	28.24	8.47	8.47
Skeletal Muscle Cells, donor1	11281-116I3	334.84	216.25	30.35	28.33	0.18	5.89	1.32	2.20
Skeletal Muscle Cells, donor2	11358-117H8	378.05	606.47	70.84	33.97	0.00	10.84	5.06	5.78
Skeletal Muscle Cells, donor3	11430-118G8	1749.83	1438.82	249.14	160.52	7.52	17.56	30.10	5.02
Skeletal Muscle Cells, donor4	11451-119A2	497.99	358.80	48.54	53.25	1.26	11.15	9.11	2.98
Skeletal Muscle Cells, donor5	11455-119A6	507.92	322.11	58.12	53.07	1.19	8.62	7.73	3.86
Skeletal Muscle Cells, donor6	11459-119B1	442.16	318.42	75.87	69.87	1.23	8.00	8.31	3.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	323.46	314.39	37.55	29.23	0.13	9.83	4.16	2.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	421.79	380.69	28.11	27.40	0.86	7.13	2.43	3.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	432.65	387.71	43.16	39.58	0.89	8.14	4.66	2.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	287.72	380.31	48.28	27.89	1.01	8.59	2.44	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	632.57	656.45	99.16	70.21	0.72	15.20	6.51	5.07
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	429.58	421.88	35.50	34.54	1.65	7.16	5.23	4.95
Skin - palm, donor1	10286-104F7	386.80	252.49	5.37	2.69	2.69	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	792.00	382.88	46.71	35.32	0.43	4.32	3.75	12.54
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	388.50	199.57	58.07	35.99	0.82	1.64	1.64	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	772.99	366.37	53.49	43.75	1.04	5.19	3.76	11.04
Small Airway Epithelial Cells, donor1	11256-116F5	633.04	306.93	24.05	27.11	0.83	2.22	0.70	7.92
Small Airway Epithelial Cells, donor2	11334-117F2	683.87	278.50	21.10	20.25	0.00	2.25	0.56	5.34
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	524.39	340.85	39.33	39.12	0.00	2.33	2.33	2.96
Small Airway Epithelial Cells, donor3	11406-118E2	632.28	239.24	17.46	18.21	0.00	2.10	0.45	5.55
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	873.91	1055.05	121.89	89.80	5.25	22.53	14.50	16.66
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	593.18	793.28	117.17	72.92	2.45	17.56	13.78	7.34
Smooth Muscle Cells - Aortic, donor0	11210-116A4	635.44	1136.27	124.03	89.35	4.11	12.93	7.05	5.29
Smooth Muscle Cells - Aortic, donor1	11283-116I5	656.12	747.17	93.92	57.90	264.31	8.84	4.86	5.52
Smooth Muscle Cells - Aortic, donor2	11360-117I1	631.23	1238.83	97.66	66.55	3.94	19.69	8.27	5.12
Smooth Muscle Cells - Aortic, donor3	11432-118H1	679.09	1232.24	115.89	122.07	3.09	12.36	6.95	5.41
Smooth Muscle Cells - Bladder, donor1	11519-119H7	490.37	282.21	11.01	10.01	1.00	6.00	2.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	562.12	1343.29	111.52	88.63	1.06	11.18	7.05	4.66
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	426.02	912.33	100.41	58.52	3.32	17.73	16.62	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	344.40	652.19	73.49	52.36	2.82	12.42	12.03	5.63
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	268.29	306.71	20.19	12.05	0.65	16.93	8.47	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	194.62	403.41	16.54	11.81	0.89	10.04	3.25	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	385.81	443.75	16.09	10.82	1.14	4.41	2.70	1.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	330.88	485.75	45.71	47.66	1.30	6.18	4.55	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	299.87	222.84	9.44	8.22	0.91	3.04	1.22	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	1277.97	1248.42	91.93	52.28	2.78	17.17	11.87	5.30
Smooth Muscle Cells - Carotid, donor2	11362-117I3	991.56	1560.78	140.78	97.93	0.00	6.12	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1451.97	1471.99	171.18	135.90	1.43	26.23	12.87	13.83
Smooth Muscle Cells - Colonic, donor1	11239-116D6	269.29	287.13	29.05	21.97	0.44	5.75	1.92	2.21
Smooth Muscle Cells - Colonic, donor2	11320-117D6	306.07	364.40	30.78	21.74	0.22	5.38	3.23	5.38
Smooth Muscle Cells - Colonic, donor3	11396-118D1	329.57	398.32	40.20	25.19	1.36	4.51	3.04	3.46
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	685.69	1248.41	87.39	75.48	3.25	13.15	11.29	4.95
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	771.76	2058.74	145.51	78.69	4.31	7.55	14.01	14.01
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	473.99	564.84	67.24	40.64	0.60	13.45	9.56	5.38
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	396.02	502.54	56.33	50.53	2.05	7.51	5.80	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	525.05	446.99	48.37	34.79	0.71	13.19	3.77	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	506.33	770.81	81.92	40.36	2.62	11.17	6.94	13.08
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	525.42	760.03	87.84	53.02	2.05	8.42	9.78	3.41
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1137.58	1635.12	200.47	137.07	5.43	25.96	15.10	14.49
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	383.88	398.45	36.56	42.12	0.79	6.89	4.50	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	352.21	422.11	40.48	24.77	2.66	6.66	3.99	2.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	343.35	604.81	57.60	38.07	2.75	10.64	4.88	6.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	241.23	358.43	15.73	10.91	0.76	7.36	1.27	3.30
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	440.26	624.50	101.92	71.77	2.11	14.62	6.78	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	631.64	845.44	70.52	49.51	3.00	11.25	5.25	8.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	547.90	298.50	23.26	14.21	2558.59	7.75	2.58	10.34
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	1268.25	1693.79	205.56	151.15	3.26	34.88	13.49	12.09
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	886.57	1266.75	110.57	76.74	1.01	12.12	7.57	7.57
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	859.01	1295.89	110.00	73.96	3.45	11.28	15.04	11.91
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	228.92	419.49	35.99	33.63	1.18	4.42	1.18	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	231.68	278.33	24.74	25.41	1.00	2.00	3.50	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	351.30	327.01	14.48	12.61	1.40	4.67	1.40	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	776.73	1619.08	122.19	89.52	3.74	12.95	10.51	7.20
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	726.62	1369.11	127.73	91.27	1.02	11.73	7.14	8.92
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	983.60	1102.82	104.92	75.21	2.82	14.29	10.15	7.33
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	281.58	366.41	34.24	34.66	0.56	4.61	4.47	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	389.20	504.82	23.63	18.27	0.50	3.85	2.43	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	596.66	539.04	106.66	82.86	2.38	16.19	2.38	4.29
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	696.55	1686.21	114.26	82.21	2.45	13.46	12.23	6.61
Smooth Muscle Cells - Uterine, donor1	11258-116F7	505.97	605.62	35.57	23.20	2.65	5.74	4.42	4.42
Smooth Muscle Cells - Uterine, donor3	11466-119B8	593.35	598.91	35.99	30.14	2.05	2.93	1.17	4.39
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	381.14	198.25	20.99	11.27	0.97	5.05	4.08	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	341.14	464.91	72.99	34.38	2.12	6.88	15.07	6.35
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	290.86	251.06	24.55	10.79	1.86	5.95	4.46	5.58
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	397.79	593.98	40.25	17.25	4.31	5.39	5.03	10.06
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	216.90	451.97	53.37	34.64	1.42	5.39	7.10	4.83
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	319.43	259.95	14.97	11.03	0.39	2.76	3.15	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	330.64	350.45	64.50	28.95	1.52	11.68	13.97	5.59
Smooth muscle cells - airway, control, donor2	11967-126D5	819.80	370.97	44.72	25.16	1.60	6.39	3.99	7.19
Smooth muscle cells - airway, control, donor3	11968-126D6	201.06	234.08	42.22	23.41	1.25	7.11	9.61	4.60
Smooth muscle cells - airway, control, donor4	11969-126D7	252.10	186.09	19.25	11.92	1.38	8.71	1.83	3.21
Synoviocyte, donor1	11291-117A4	489.48	778.65	41.58	27.44	1.35	9.76	7.91	4.71
Synoviocyte, donor2	11368-117I9	345.47	484.94	50.79	32.52	0.34	7.54	9.05	2.68
Synoviocyte, donor3	11440-118H9	422.47	376.45	39.77	23.90	0.67	11.39	4.92	2.23
Trabecular Meshwork Cells, donor1	11532-120A2	433.80	416.29	42.52	51.81	4.65	4.65	3.22	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	612.45	455.87	114.96	79.28	0.00	3.96	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	520.98	391.31	35.20	41.68	1.62	4.40	1.85	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	586.88	345.59	81.00	82.65	0.36	9.03	1.08	2.44
Tracheal Epithelial Cells, donor2	11369-118A1	1332.10	858.56	146.51	153.85	0.39	8.50	2.71	10.44
Tracheal Epithelial Cells, donor3	11441-118I1	1319.41	612.18	91.05	104.80	1.15	8.59	2.86	7.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	205.33	108.02	12.55	14.27	0.00	3.94	3.44	1.48
Urethra, donor2	10319-105A4	348.89	240.99	16.19	25.18	0.00	10.79	7.19	0.00
Urothelial Cells, donor1	11520-119H8	799.11	502.63	47.82	54.19	0.80	4.52	2.39	3.19
Urothelial Cells, donor2	11600-120H7	813.95	459.05	43.66	52.87	0.00	4.81	1.60	5.21
Urothelial Cells, donor3	11681-122H7	1132.73	373.15	35.53	41.49	0.46	2.98	1.38	5.27
Urothelial cells, donor0	11216-116B1	731.99	258.78	17.83	15.60	0.67	3.79	0.89	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	403.07	322.99	52.50	38.26	0.00	13.35	3.56	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	407.44	307.37	50.04	55.75	0.00	15.73	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	412.77	328.57	34.23	35.60	0.00	8.90	3.42	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	249.30	223.13	40.98	39.60	0.00	13.43	3.79	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	279.47	212.08	28.47	45.32	0.00	14.53	5.81	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	407.13	242.61	40.61	36.44	0.00	16.66	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	357.94	248.72	44.05	39.47	0.00	12.85	1.84	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	309.47	328.64	29.21	24.65	0.00	10.95	2.74	0.91
Wilms' tumor cell line:G-401	10809-111A8	141.37	318.52	34.91	27.51	7.03	6.66	3.33	2.84
Wilms' tumor cell line:HFWT	10597-108E3	296.57	229.69	21.12	14.08	0.00	5.28	0.88	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1066.16	325.13	8.10	4.19	0.56	9.50	4.47	3.63
achilles tendon, donor2	10292-104G4	247.98	185.99	26.86	12.40	22.73	8.27	0.00	14.47
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	401.05	186.37	164.19	157.82	0.00	34.67	5.35	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	250.52	218.01	169.95	205.47	0.00	57.81	10.22	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	123.69	83.81	160.02	97.82	0.00	34.43	9.14	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	97.42	211.16	290.07	189.12	0.00	61.77	10.88	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	217.56	193.39	303.01	243.42	0.56	29.23	18.27	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	237.28	252.51	234.11	126.04	0.63	33.63	12.27	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	184.29	267.86	226.21	62.34	0.54	23.68	4.63	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	152.02	210.63	282.01	180.22	0.00	18.95	9.69	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	247.87	225.01	259.31	164.98	0.00	40.84	8.17	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	306.76	270.64	347.14	284.23	0.39	92.03	36.89	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	523.66	448.59	210.50	196.70	0.37	47.66	15.82	4.42
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	245.73	245.73	156.02	159.92	3.90	39.01	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	198.45	337.88	241.91	168.24	1.16	39.74	19.75	2.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	225.24	211.52	394.57	207.38	0.26	39.09	10.10	4.14
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	280.26	242.85	360.04	181.19	0.58	30.39	9.35	4.38
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	399.69	206.35	80.40	53.45	0.00	9.76	4.18	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	224.13	313.37	232.77	122.14	0.41	27.55	9.87	5.76
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	284.24	269.81	75.82	47.27	0.92	24.56	12.58	3.38
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	247.49	328.14	323.02	167.70	0.85	42.24	20.91	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	223.83	336.05	282.37	161.96	0.61	37.61	15.77	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	238.30	322.55	279.22	164.16	0.24	46.46	14.20	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	199.57	198.46	276.42	218.06	0.89	20.27	5.79	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	584.37	272.51	169.78	117.74	1.00	24.68	10.01	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	354.92	211.84	37.16	27.87	0.00	26.01	3.72	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	365.36	601.90	201.14	112.62	1.13	30.51	17.33	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	126.91	160.93	140.00	93.77	0.00	21.81	4.36	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	314.91	292.42	114.34	103.10	0.00	18.74	9.37	0.00
adenocarcinoma cell line:IM95m	10796-110I4	348.30	430.02	66.65	134.47	0.47	34.15	16.25	4.95
adipose tissue, adult, pool1	10010-101C1	235.01	213.91	19.08	22.34	66.24	7.14	6.36	3.10
adipose, donor1	10184-103D4	48.09	65.09	5.86	11.73	0.59	27.56	4.10	7.04
adipose, donor2	10185-103D5	1048.67	195.87	27.17	33.25	2.03	49.47	24.33	8.92
adipose, donor3	10186-103D6	272.83	82.78	11.71	11.44	2.45	16.07	5.72	6.81
adipose, donor4	10187-103D7	227.09	143.88	24.27	26.00	0.87	27.74	6.07	10.40
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	163.82	447.89	15.62	23.04	0.63	2.37	1.74	2.05
adrenal gland, adult, pool1	10081-102A9	400.14	214.62	18.19	25.46	0.00	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	317.77	395.82	215.18	188.10	0.13	19.88	6.27	2.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	180.08	414.11	275.12	182.22	0.71	17.86	14.65	4.64
amniotic membrane cells, donor1	12235-129G3	358.67	262.69	57.03	45.44	0.23	12.06	6.03	3.01
amniotic membrane cells, donor2	12236-129G4	181.22	109.88	16.91	9.47	1.01	2.70	2.03	3.04
amniotic membrane cells, donor3	12237-129G5	453.39	283.11	82.49	61.87	1.18	28.87	7.66	4.42
amygdala - adult, donor10196	10167-103B5	321.35	762.47	35.57	85.38	2.37	34.39	36.76	5.93
amygdala, adult, donor10252	10151-102I7	349.57	820.80	43.80	57.59	1.01	41.57	15.41	2.64
amygdala, newborn, donor10223	10360-105E9	254.34	378.61	29.05	28.40	3.55	38.41	14.85	3.23
anaplastic carcinoma cell line:8305C	10428-106D5	785.12	182.97	6.49	3.82	0.51	3.44	0.76	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	228.79	444.56	628.78	327.63	0.88	63.76	53.61	5.52
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	212.78	179.38	34.41	62.80	0.33	12.69	3.34	2.00
aorta, adult, pool1	10052-101G7	151.81	338.13	50.80	58.25	3.92	20.40	12.16	1.57
appendix, adult	10189-103D9	361.73	256.93	36.09	42.69	1.16	12.03	2.33	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	334.30	332.59	208.42	173.00	4.47	37.83	12.38	2.75
artery, adult	10190-103E1	1097.82	1880.43	304.35	376.36	12812.44	42.12	43.48	52.99
astrocytoma cell line:TM-31	10425-106D2	281.62	228.75	14.92	18.83	0.87	8.26	2.90	0.87
b cell line:RPMI1788	10427-106D4	486.70	421.57	145.58	194.20	0.15	55.47	8.03	1.78
basal cell carcinoma cell line:TE 354.T	10702-109G9	352.64	1225.76	47.17	29.41	0.83	9.99	4.44	6.10
bile duct carcinoma cell line:HuCCT1	10432-106D9	464.31	123.94	2.78	2.48	0.50	1.69	0.60	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	470.67	161.85	124.03	107.79	0.67	18.08	4.69	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	356.23	217.54	252.78	104.58	0.56	35.23	14.54	7.27
bladder, adult, pool1	10011-101C2	353.41	505.51	45.74	40.85	0.87	13.04	7.82	6.30
blood, adult, pool1	10053-101G8	422.99	312.26	35.43	53.15	0.00	17.72	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	107.04	239.78	1.71	1.71	0.00	0.00	0.00	1.71
bone marrow, adult	10192-103E3	427.16	265.88	24.29	18.90	2.70	10.12	5.40	2.02
brain, adult, donor1	10084-102B3	476.66	644.77	23.58	57.40	3.08	48.18	31.78	5.13
brain, adult, pool1	10012-101C3	433.41	727.50	38.98	59.80	1.34	43.32	30.18	4.57
brain, fetal, pool1	10085-102B4	227.07	280.50	8.01	10.69	2.67	37.40	8.01	5.34
breast carcinoma cell line:MCF7	10482-107A5	1113.33	599.94	55.50	34.03	0.66	14.87	3.96	9.58
breast carcinoma cell line:MDA-MB-453	10419-106C5	1126.90	1226.01	698.76	434.63	3.74	37.95	36.95	4.62
breast, adult, donor1	10080-102A8	401.54	117.43	8.84	12.63	1.26	3.79	8.21	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	672.03	768.07	267.92	473.98	2.03	55.13	18.55	5.84
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	589.99	410.03	115.34	99.88	0.00	17.93	6.18	4.02
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	336.81	560.12	124.32	213.64	1.15	35.22	1.84	6.45
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	388.79	415.42	75.77	51.81	1.21	24.45	13.31	1.69
carcinoid cell line:NCI-H1770	10703-109H1	704.31	194.18	67.70	112.37	0.94	16.93	11.28	4.23
carcinoid cell line:NCI-H727	10735-110B6	459.62	376.27	74.49	57.64	1.53	9.08	12.14	3.06
carcinoid cell line:SK-PN-DW	10719-109I8	1105.02	887.94	169.22	183.80	0.00	106.48	57.36	9.19
carcinosarcoma cell line:JHUCS-1	10642-109A3	418.43	318.08	84.64	59.89	3.73	17.83	13.58	3.73
caudate nucleus - adult, donor10196	10177-103C6	247.53	416.78	42.60	92.11	1.15	34.54	40.30	4.61
caudate nucleus, adult, donor10252	10164-103B2	246.14	626.47	56.39	99.22	1.34	59.40	22.09	2.01
caudate nucleus, adult, donor10258	10379-105H1	335.46	626.59	51.20	106.98	1.53	75.65	35.91	3.06
caudate nucleus, newborn, donor10223	10354-105E3	331.07	280.53	42.12	63.36	0.37	93.76	31.50	3.66
cerebellum - adult, donor10196	10173-103C2	250.54	349.59	40.79	93.22	5.83	78.66	43.70	2.91
cerebellum, adult, donor10252	10166-103B4	279.49	335.64	30.75	56.58	0.85	33.73	10.68	1.71
cerebellum, adult, pool1	10083-102B2	255.26	280.10	38.63	71.06	1.72	84.17	46.91	3.10
cerebellum, newborn, donor10223	10357-105E6	235.80	109.60	20.76	13.28	0.83	43.17	13.28	1.66
cerebral meninges, adult	10188-103D8	318.20	570.84	36.56	41.60	1.26	37.82	23.45	6.81
cerebrospinal fluid, donor2	10294-104G6	587.63	648.29	74.55	94.28	3948.97	23.39	13.16	70.16
cervical cancer cell line:D98-AH2	10552-107I3	136.74	252.77	63.70	134.01	1.58	47.88	9.20	0.86
cervical cancer cell line:ME-180	10553-107I4	622.43	292.66	0.00	0.17	0.33	0.66	0.17	0.83
cervix, adult, pool1	10013-101C4	231.61	236.44	25.83	27.09	0.42	11.34	6.19	2.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	371.76	324.66	1.11	1.39	0.28	0.84	0.56	1.95
chondrosarcoma cell line:SW 1353	10700-109G7	795.51	454.58	24.82	7.84	0.00	2.61	1.31	3.92
choriocarcinoma cell line:BeWo	10423-106C9	692.84	186.17	21.38	32.19	0.75	12.68	4.23	6.09
choriocarcinoma cell line:SCH	10785-110H2	426.19	162.02	5.17	2.59	2.34	6.04	4.56	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	504.24	59.29	1.19	6.17	0.00	1.90	0.24	2.13
chorionic membrane cells, donor1	12238-129G6	448.75	265.54	35.33	18.80	0.57	8.26	7.41	2.85
chorionic membrane cells, donor2	12239-129G7	247.19	237.94	17.70	16.01	1.59	3.08	4.18	3.88
chorionic membrane cells, donor3	12240-129G8	658.28	291.78	28.02	20.33	1.65	7.14	1.65	7.69
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	460.47	269.62	512.98	321.12	5.05	50.49	24.24	6.06
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	314.66	445.28	365.76	276.24	0.00	34.96	23.05	4.80
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	256.38	327.76	110.66	85.11	0.42	21.54	8.87	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1461.20	680.52	93.73	93.22	2.82	29.28	12.33	5.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1681.29	820.45	99.65	108.12	3.14	30.72	15.96	5.32
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1615.85	783.08	105.67	104.66	2.65	30.34	12.22	3.66
chronic myelogenous leukemia cell line:K562	10454-106G4	491.15	356.29	54.18	78.33	0.59	27.09	2.94	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	250.98	258.02	100.08	104.51	0.26	27.37	22.15	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	511.57	579.45	76.12	151.32	0.00	36.12	7.77	6.17
clear cell carcinoma cell line:TEN	10636-108I6	544.12	341.81	74.43	78.60	0.69	27.76	4.86	3.12
colon carcinoma cell line:CACO-2	10513-107D9	247.66	190.55	43.38	55.28	0.00	13.36	2.20	0.73
colon carcinoma cell line:COLO-320	10420-106C6	382.74	148.61	61.95	101.10	0.00	26.61	4.94	0.38
colon, adult, donor1	10082-102B1	624.77	357.01	20.23	20.23	0.00	5.95	2.38	3.57
colon, adult, pool1	10014-101C5	309.03	257.10	22.33	25.73	0.82	6.11	5.41	4.00
colon, fetal, donor1	10070-101I7	1179.74	395.51	37.70	32.14	0.62	10.51	14.21	13.60
common myeloid progenitor CMP, donor1	12130-128D6	142.09	77.92	4.58	4.58	0.00	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	225.33	125.18	100.15	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	75.64	128.33	91.79	75.21	0.85	7.65	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	119.54	281.94	164.67	164.21	1.21	16.15	2.72	3.17
cord blood derived cell line:COBL-a untreated	10449-106F8	124.37	327.57	193.19	174.01	0.99	16.92	4.09	0.85
corpus callosum, adult, pool1	10042-101F6	324.50	242.24	32.28	39.91	1.44	23.55	13.16	1.88
cruciate ligament, donor2	10295-104G7	239.90	205.05	17.02	19.45	10.54	6.48	5.67	5.67
diaphragm, fetal, donor1	10069-101I6	743.17	633.22	121.99	99.52	5461.44	15.25	15.25	23.27
diencephalon, adult	10193-103E4	369.82	445.90	30.96	45.12	1.68	32.64	18.00	5.52
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	235.12	241.78	258.77	284.26	0.23	41.79	5.05	2.30
ductal cell carcinoma cell line:KLM-1	10438-106E6	360.30	204.64	3.08	6.92	0.26	2.31	0.51	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	103.27	335.57	189.45	124.93	2.17	15.17	5.78	1.44
ductus deferens, adult	10196-103E7	348.34	379.24	27.91	25.42	0.50	9.47	9.47	3.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	275.08	126.74	33.13	27.36	2.88	10.08	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	289.11	208.92	28.69	36.05	2.21	11.77	2.94	6.62
dura mater, adult, donor1	10041-101F5	158.65	249.00	69.70	48.15	0.91	16.19	5.86	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	245.83	116.14	53.96	78.84	3.78	13.32	13.77	4.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	289.74	230.70	60.76	70.79	4.01	48.58	39.12	2.87
embryonic pancreas cell line:1B2C6	10604-108F1	196.08	128.87	13.57	20.35	0.00	1.85	0.00	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	179.51	214.62	34.81	42.98	0.00	2.12	1.51	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	192.66	162.71	31.49	41.99	0.31	3.70	1.23	1.23
embryonic pancreas cell line:2C6	10603-108E9	218.04	143.17	24.96	26.27	0.00	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	447.82	451.84	36.20	30.84	2.35	17.09	7.37	3.69
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	157.31	188.48	25.92	49.48	0.00	19.21	1.09	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	723.82	471.66	3.70	3.70	0.32	2.09	0.48	3.86
epidermoid carcinoma cell line:A431	10426-106D3	552.12	438.63	23.01	26.57	0.67	7.11	2.89	2.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	493.28	361.19	50.37	48.06	1.21	7.04	9.02	1.10
epididymis, adult	10197-103E8	344.94	460.07	45.63	34.12	86.86	8.58	7.12	6.07
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	786.64	562.92	42.76	26.97	12.06	16.14	9.40	3.55
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	154.54	267.01	97.52	68.03	3.54	16.12	9.83	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	320.55	395.38	129.08	180.72	7.47	25.03	9.57	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	272.62	342.50	94.88	119.97	7.09	21.36	8.96	1.48
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	314.58	415.18	126.37	173.53	6.39	23.64	10.98	2.35
esophagus, adult, pool1	10015-101C6	533.86	432.36	35.36	34.93	87.17	9.45	3.82	9.13
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	107.58	217.53	131.87	62.74	0.50	22.79	7.76	1.38
eye - muscle inferior rectus, donor1	10272-104E2	376.67	451.53	26.56	43.46	212.48	7.24	9.66	9.66
eye - muscle lateral, donor2	10298-104H1	1024.75	902.70	138.88	113.63	643.89	18.94	18.94	29.46
eye - muscle medial, donor2	10299-104H2	745.60	596.77	63.99	52.09	488.13	10.42	8.93	8.93
eye - muscle superior, donor2	10297-104G9	463.18	366.88	41.27	61.91	275.16	5.73	6.88	5.73
eye - vitreous humor, donor1	10268-104D7	362.89	170.51	33.52	16.03	4.37	10.20	4.37	4.37
eye, fetal, donor1	10054-101G9	651.86	395.33	59.75	70.68	31.78	75.00	71.95	3.05
fibrosarcoma cell line:HT-1080	10758-110E2	704.46	490.59	1.15	0.38	0.26	2.95	1.92	3.59
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	811.50	637.23	44.63	30.63	1.42	22.55	11.40	5.46
frontal lobe, adult, pool1	10040-101F4	364.60	744.59	36.78	59.95	1.13	39.69	12.38	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	334.48	166.34	30.02	18.32	2.10	10.51	5.10	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	295.52	329.17	7.86	5.21	0.09	4.30	2.93	0.73
gall bladder, adult	10198-103E9	281.51	325.93	35.73	36.94	0.97	14.00	9.17	4.59
gamma delta positive T cells, donor1	11937-126A2	64.42	226.55	99.32	67.64	0.00	13.42	3.76	0.54
gamma delta positive T cells, donor2	11938-126A3	78.43	181.89	88.52	51.54	0.00	9.71	1.49	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	521.28	205.09	0.21	0.21	0.00	2.53	1.48	3.59
gastric adenocarcinoma cell line:MKN45	10612-108F9	249.70	355.11	153.57	149.32	0.97	13.15	10.44	1.55
gastric cancer cell line:AZ521	10549-107H9	174.61	242.00	36.40	63.45	0.33	12.79	2.46	0.33
gastric cancer cell line:GSS	10560-108A2	395.38	314.84	48.51	61.32	0.00	10.98	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	216.12	106.69	157.64	116.97	1.83	19.88	8.91	1.83
giant cell carcinoma cell line:LU65	10487-107B1	112.22	104.07	41.77	51.63	0.11	2.75	1.26	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	369.49	230.23	56.96	54.02	0.28	20.57	14.98	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	467.41	267.38	32.92	47.39	0.50	9.73	3.24	3.99
glioblastoma cell line:A172, tech_rep1	10444-106F3	392.76	265.04	10.77	7.18	0.42	11.93	7.49	1.90
glioblastoma cell line:A172, tech_rep2	10444-106F3	405.17	308.68	11.94	7.16	0.98	12.92	3.93	2.25
glioblastoma cell line:T98G	10485-107A8	511.36	532.66	79.47	51.21	1.10	14.90	5.96	1.88
glioma cell line:GI-1	10413-106B8	188.91	221.42	45.98	26.36	0.88	14.35	10.84	0.59
globus pallidus - adult, donor10196	10175-103C4	270.43	263.14	21.87	43.01	0.73	26.24	20.41	3.64
globus pallidus, adult, donor10252	10161-103A8	295.11	321.96	54.43	72.98	1.71	29.05	12.69	1.95
globus pallidus, adult, donor10258	10367-105F7	265.63	180.74	38.34	38.34	1.37	49.29	24.65	5.48
globus pallidus, newborn, donor10223	10364-105F4	333.61	166.27	31.44	26.11	1.07	18.12	10.13	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	154.17	117.46	24.47	19.58	2.45	7.34	4.89	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	174.85	174.85	229.50	142.07	0.00	21.86	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	177.70	209.06	209.06	209.06	0.00	41.81	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	660.15	367.03	2.24	2.24	0.64	6.40	4.48	5.44
hIPS +CCl2, biol_rep1	14383-156B9	303.93	267.66	20.66	41.78	2.30	29.84	9.18	0.46
hIPS +CCl2, biol_rep2	14384-156C1	254.24	248.29	21.49	55.33	2.29	25.61	10.52	2.74
hIPS +CCl2, biol_rep3	14385-156C2	253.77	284.04	23.83	59.90	3.86	10.95	5.80	1.29
hIPS, biol_rep1	14380-156B6	171.04	195.47	11.50	58.93	1.44	2.87	2.87	4.31
hIPS, biol_rep2	14381-156B7	232.51	245.54	16.46	51.44	4.80	15.77	4.12	3.43
hIPS, biol_rep3	14382-156B8	324.42	417.11	37.52	68.42	2.21	26.48	15.45	1.10
hairy cell leukemia cell line:Mo	10712-109I1	257.75	362.91	306.88	185.34	0.29	20.69	4.60	1.72
heart - mitral valve, adult	10205-103F7	242.46	584.48	60.99	29.90	8.97	19.73	11.96	4.78
heart - pulmonic valve, adult	10206-103F8	217.02	747.30	122.63	48.11	5.23	31.38	30.85	3.66
heart - tricuspid valve, adult	10207-103F9	330.56	373.02	74.94	39.13	1.67	6.66	5.83	7.49
heart, adult, diseased post-infarction, donor1	10050-101G5	333.43	769.09	121.62	75.91	4.90	9.39	8.77	3.26
heart, adult, diseased, donor1	10051-101G6	503.33	1288.57	268.27	168.63	4.68	27.25	14.48	8.09
heart, adult, pool1	10016-101C7	325.65	1389.29	190.19	86.93	3.68	19.55	30.82	8.28
heart, fetal, pool1	10046-101G1	616.18	1118.49	142.21	64.07	5.96	33.06	13.96	2.57
hepatic mesenchymal tumor cell line:LI90	10778-110G4	686.47	757.73	12.34	12.96	0.31	6.17	4.94	7.40
hepatoblastoma cell line:HuH-6	10633-108I3	657.61	176.00	5.95	21.41	8.32	5.95	2.38	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	476.35	607.40	381.32	340.77	6.52	22.87	13.70	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	428.94	593.76	353.08	325.77	3.88	19.66	18.45	3.40
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	499.20	668.77	418.16	371.57	5.66	19.30	18.29	2.93
hepatoma cell line:Li-7	10484-107A7	175.72	84.08	49.38	36.59	0.89	10.90	10.90	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	214.37	288.74	352.96	353.26	1.41	29.25	19.70	1.71
hippocampus - adult, donor10196	10169-103B7	311.34	700.28	29.34	51.10	0.95	33.12	22.71	4.73
hippocampus, adult, donor10252	10153-102I9	390.85	657.81	32.25	51.64	1.63	27.15	11.63	4.08
hippocampus, adult, donor10258	10374-105G5	172.29	601.03	42.33	61.75	2.99	11.95	6.97	6.97
hippocampus, newborn, donor10223	10363-105F3	243.56	315.11	27.49	35.60	0.70	31.37	20.80	7.40
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	449.82	322.87	84.23	101.93	1.22	82.40	36.01	12.82
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	577.68	359.72	45.95	75.60	1.57	62.83	19.44	7.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	518.45	327.53	59.41	77.44	1.27	55.10	27.17	9.65
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	166.90	129.69	9.59	19.74	0.00	34.40	9.02	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	188.24	144.86	8.26	18.33	0.52	44.41	7.23	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	192.08	187.15	8.35	22.02	0.38	58.08	9.87	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	386.55	123.79	10.51	12.26	1.75	26.28	9.34	9.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	593.94	172.99	18.10	24.34	2.37	38.99	13.14	11.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	244.82	108.86	5.00	7.09	2.92	10.84	5.84	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	211.69	135.92	7.34	7.81	1.89	7.34	2.84	3.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	306.17	146.09	8.84	7.71	2.57	10.93	3.38	3.86
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	214.78	138.03	14.81	7.41	5.39	6.06	2.69	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	581.65	348.80	69.32	95.30	1.88	59.62	19.72	9.08
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	480.49	311.97	78.61	106.12	2.46	49.62	30.46	9.33
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	468.67	240.88	89.89	108.22	6.11	100.37	31.42	16.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	162.46	141.08	6.11	11.65	0.57	33.79	6.11	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	136.49	123.84	4.36	11.77	0.44	35.32	6.54	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	116.44	100.45	7.00	7.00	1.50	20.49	10.00	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1385.24	278.25	42.76	42.01	3.58	85.53	27.13	30.33
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1362.33	260.55	43.20	37.29	3.18	80.03	36.38	22.74
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1080.66	208.30	44.79	33.83	5.64	73.92	40.41	14.72
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	252.79	130.97	13.06	10.78	1.14	17.64	7.19	4.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	247.92	125.41	11.32	10.16	2.90	17.13	10.45	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	261.26	105.22	13.15	11.06	2.99	20.33	12.55	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	527.82	327.74	42.68	67.43	1.11	48.59	17.18	7.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	455.31	305.82	42.51	71.89	2.28	52.78	19.97	8.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	452.41	299.70	62.06	94.32	1.63	59.21	40.83	8.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	184.14	168.29	13.03	17.96	3.52	28.52	11.27	6.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	170.09	148.23	10.77	17.10	2.53	26.61	7.60	5.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	184.60	168.56	10.59	13.32	0.91	33.29	12.71	5.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	600.38	175.30	27.41	23.79	7.24	40.34	24.82	7.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	530.00	187.29	23.25	24.57	3.98	33.87	27.89	5.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	366.84	131.86	26.42	16.42	6.93	28.48	18.47	5.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	230.85	158.25	11.25	5.62	6.39	8.95	7.41	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	253.67	131.00	3.79	8.33	11.36	15.90	6.06	5.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	252.04	146.52	9.07	7.06	3.02	9.41	8.74	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	498.71	319.27	41.78	82.84	2.17	56.51	13.28	5.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	452.34	268.29	61.50	67.29	2.23	65.07	25.85	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	504.39	293.66	60.98	80.00	2.44	50.24	32.20	10.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	131.11	143.33	7.03	12.53	0.31	27.20	5.50	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	120.37	22.77	22.77	0.00	32.53	9.76	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	119.47	129.40	10.26	17.87	0.66	46.66	13.90	6.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	721.34	195.39	24.08	28.46	7.11	51.45	13.14	9.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	656.10	162.49	28.59	23.16	4.70	37.27	18.82	9.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	641.99	160.50	22.42	23.49	5.69	49.11	21.35	12.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	278.06	112.18	7.16	8.35	4.77	4.77	4.77	5.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	267.47	127.30	6.77	8.13	1.49	8.26	3.39	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	270.47	105.33	6.73	4.58	1.89	5.12	3.23	2.42
immature langerhans cells, donor1	11904-125F5	141.90	182.58	34.87	16.47	0.48	14.04	6.05	2.18
immature langerhans cells, donor2	11905-125F6	257.44	254.27	40.40	28.52	0.00	19.80	11.88	0.79
insula, adult, pool1	10039-101F3	417.24	927.88	44.10	65.86	1.61	46.84	16.66	2.65
keratoacanthoma cell line:HKA-1	10791-110H8	738.41	420.09	4.23	3.90	0.00	6.18	2.93	3.25
kidney, adult, pool1	10017-101C8	394.70	303.79	26.63	24.93	0.80	9.61	3.40	5.11
kidney, fetal, pool1	10045-101F9	486.24	215.18	18.60	22.92	1.20	9.34	7.22	1.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	224.68	365.99	99.84	50.70	0.57	13.49	3.83	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	249.39	388.74	421.36	229.90	0.41	17.14	5.53	4.84
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	215.98	100.92	2.39	4.22	0.18	1.28	0.55	0.18
left atrium, adult, donor1	10079-102A7	474.02	1028.13	162.91	50.13	8.17	32.69	28.88	14.17
left ventricle, adult, donor1	10078-102A6	346.37	800.45	201.25	74.33	2.53	17.19	22.75	6.57
leiomyoblastoma cell line:G-402	10721-110A1	90.84	319.30	123.67	99.32	5.47	8.21	7.66	1.92
leiomyoma cell line:10964C	10569-108B2	422.84	911.06	58.20	30.90	8.62	10.78	4.67	14.73
leiomyoma cell line:15242A	10570-108B3	482.07	948.37	43.48	26.09	5.43	7.07	3.26	15.22
leiomyoma cell line:15425	10571-108B4	338.97	623.07	47.35	32.54	3.16	4.61	3.89	8.26
leiomyosarcoma cell line:Hs 5.T	10722-110A2	279.37	349.22	31.75	25.40	0.00	0.00	19.05	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	83.64	174.61	0.00	0.00	1.05	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	185.59	453.82	170.59	130.10	0.12	19.95	9.09	0.59
liposarcoma cell line:KMLS-1	10782-110G8	286.49	302.89	62.48	32.65	1.09	11.25	7.65	1.56
liposarcoma cell line:SW 872	10726-110A6	848.49	815.10	9.75	5.60	1.71	2.56	2.80	4.63
liver, adult, pool1	10018-101C9	114.42	88.16	23.01	23.50	0.32	4.86	6.16	1.30
liver, fetal, pool1	10086-102B5	261.52	59.26	9.41	24.46	1.88	7.53	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	747.50	296.02	17.21	20.85	3.21	19.54	9.62	2.33
locus coeruleus, adult, donor10252	10165-103B3	483.52	408.78	49.46	58.69	3.14	27.13	12.00	2.03
locus coeruleus, adult, donor10258	10375-105G6	545.65	327.56	47.96	49.94	5.36	30.75	42.32	6.77
locus coeruleus, newborn, donor10223	10362-105F2	476.56	278.87	69.40	45.43	2.94	43.74	39.96	14.30
lung adenocarcinoma cell line:A549	10499-107C4	324.95	240.25	65.88	106.56	1.66	20.48	4.43	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	670.79	503.96	63.43	51.02	2.76	23.44	11.72	4.83
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	409.29	520.67	233.97	103.34	0.40	17.27	9.62	12.65
lung, adult, pool1	10019-101D1	196.21	187.00	41.34	27.76	0.24	9.69	2.72	3.54
lung, fetal, donor1	10068-101I5	154.12	121.58	47.09	26.54	0.29	13.13	2.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	363.37	192.91	38.49	24.29	0.00	8.25	5.96	7.79
lymph node, adult, donor1	10077-102A5	306.27	279.28	70.53	72.42	0.00	31.72	8.99	0.00
lymphangiectasia cell line:DS-1	10727-110A7	344.99	424.77	273.97	195.73	0.66	28.05	11.40	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	252.50	187.00	59.01	80.75	0.45	7.24	0.30	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	74.76	56.07	16.99	11.04	0.00	4.25	0.85	1.70
mature adipocyte, donor1	12231-129F8	206.01	280.16	7.55	5.77	3.11	4.88	9.77	2.66
mature adipocyte, donor2	12232-129F9	241.98	248.20	7.68	5.81	3.53	6.85	12.24	3.53
mature adipocyte, donor3	12233-129G1	294.20	291.11	8.30	7.35	1.19	8.53	10.67	2.37
mature adipocyte, donor4	12234-129G2	242.16	246.90	8.42	4.47	3.69	7.63	12.63	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	290.91	229.92	40.03	50.51	0.00	26.45	6.43	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	470.39	782.85	34.97	82.35	1.13	38.35	23.69	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	454.80	795.39	46.34	70.44	1.66	32.55	12.87	4.41
medial frontal gyrus, adult, donor10258	10368-105F8	557.54	739.89	47.65	66.08	2.22	41.30	31.13	4.45
medial frontal gyrus, newborn, donor10223	10352-105E1	105.34	274.23	38.38	21.32	2.56	22.60	15.35	4.69
medial temporal gyrus - adult, donor10196	10183-103D3	500.01	835.15	43.88	68.68	2.19	55.18	31.05	6.58
medial temporal gyrus, adult, donor10252	10156-103A3	386.67	824.70	40.53	73.22	1.06	37.14	13.58	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	238.86	483.49	30.82	65.49	3.85	25.04	13.48	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	143.54	444.96	43.06	71.77	0.00	14.35	14.35	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	228.28	438.62	24.41	27.64	2.51	30.15	8.61	3.95
medulla oblongata - adult, donor10196	10174-103C3	323.19	212.86	22.71	25.31	4.54	16.87	18.82	7.14
medulla oblongata, adult, donor10252	10155-103A2	454.97	307.60	32.82	46.60	1.08	21.36	17.34	2.79
medulla oblongata, adult, pool1	10038-101F2	478.25	326.35	26.37	33.14	2.37	21.30	8.41	0.82
medulla oblongata, newborn, donor10223	10361-105F1	455.15	172.90	30.55	21.53	1.04	13.89	5.90	3.12
medulloblastoma cell line:D283 Med	10838-111E1	225.84	261.93	27.68	43.84	0.22	103.62	76.83	1.55
medulloblastoma cell line:ONS-76	10759-110E3	422.82	356.30	72.39	83.15	0.73	14.31	8.31	2.93
melanoma cell line:COLO 679	10514-107E1	802.82	283.90	20.41	19.84	0.14	8.62	2.30	5.03
melanoma cell line:G-361	10465-106H6	394.98	304.31	1.09	0.54	0.00	4.34	1.63	4.89
meningioma cell line:HKBMM	10691-109F7	446.29	217.63	0.18	0.00	0.00	2.35	1.27	2.17
merkel cell carcinoma cell line:MKL-1	10843-111E6	414.14	210.60	74.02	124.24	3.52	40.53	11.46	11.46
merkel cell carcinoma cell line:MS-1	10844-111E7	222.93	139.20	18.92	45.36	0.52	32.92	8.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	421.33	574.00	81.47	62.45	1.53	14.42	12.12	2.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	365.56	395.19	47.99	28.36	0.36	5.82	5.45	2.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	380.56	479.53	48.45	35.61	7.87	8.70	1.24	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	277.44	363.83	46.08	37.51	0.14	6.60	8.71	1.69
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	270.75	390.34	78.38	58.54	0.96	12.13	11.94	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	343.57	410.20	54.14	29.15	0.69	5.55	4.86	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	373.65	457.23	54.41	33.98	1.03	8.92	8.41	4.12
mesenchymal precursor cell - cardiac, donor2	11753-123G7	395.08	417.51	44.17	29.44	1.27	9.43	9.66	2.30
mesenchymal precursor cell - cardiac, donor3	11754-123G8	245.78	329.07	53.85	46.03	0.53	11.54	9.95	1.59
mesenchymal precursor cell - cardiac, donor4	11755-123G9	254.96	399.58	59.42	37.54	0.81	8.91	9.99	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	440.73	472.45	46.80	38.13	0.14	5.26	6.54	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	351.75	413.34	34.25	22.73	0.99	11.20	4.94	3.62
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	590.85	645.92	63.10	41.51	0.97	10.38	8.86	2.91
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	451.02	720.86	113.80	77.50	3.84	10.82	5.24	4.54
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	622.29	801.96	50.84	36.14	0.82	10.41	10.62	5.10
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	351.19	471.96	23.72	14.38	1.44	3.95	4.31	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	723.53	849.43	82.14	56.90	0.41	15.10	16.97	2.90
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	642.02	862.72	39.21	27.36	1.37	7.07	6.38	7.52
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	399.00	526.54	61.26	43.63	3.36	7.55	7.55	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	440.24	593.57	31.23	22.71	0.45	7.02	8.82	2.69
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	569.65	565.97	52.69	46.30	0.79	9.98	8.32	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	438.48	503.27	33.87	24.67	0.37	8.47	4.05	4.05
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	452.99	584.62	25.18	15.45	0.57	4.86	3.43	3.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	597.42	615.52	116.62	70.73	1.26	11.79	8.84	7.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	282.68	370.82	21.01	20.09	0.00	7.76	7.31	3.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	242.23	371.40	22.00	21.23	1.28	9.21	3.84	3.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	271.18	397.61	21.20	22.51	0.79	9.95	4.19	4.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	257.87	373.71	17.25	18.49	0.92	8.63	6.16	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	233.94	349.74	21.18	19.30	0.94	8.00	4.94	4.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	261.63	392.61	21.66	25.05	0.68	6.77	7.11	5.08
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	277.44	388.65	16.11	16.90	1.57	9.04	7.07	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	266.45	343.83	16.22	17.61	1.85	10.66	4.63	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	241.52	144.91	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	291.88	410.71	19.61	28.84	1.44	5.77	8.94	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	266.83	375.03	15.17	24.99	1.12	7.81	5.35	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	274.96	385.76	20.91	23.55	0.48	7.69	6.01	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	198.00	272.06	16.87	19.07	2.20	7.33	4.40	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	241.67	337.34	20.14	24.84	2.01	7.38	3.36	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	243.99	365.57	20.47	18.01	0.41	8.19	5.73	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	265.47	357.82	24.06	17.18	1.29	8.59	8.16	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	218.75	298.05	27.34	24.61	0.00	10.94	5.47	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	175.61	284.07	36.15	25.82	0.00	15.49	10.33	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	208.19	312.77	17.54	25.66	1.62	10.39	6.17	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	199.33	312.82	20.37	29.10	0.00	10.18	8.73	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	264.41	331.58	20.79	22.39	2.67	8.53	4.80	5.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	185.63	293.58	13.08	16.36	0.00	8.18	9.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	220.40	302.42	18.66	21.77	0.00	7.00	5.83	3.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	188.89	251.85	8.39	33.58	0.00	12.59	8.39	16.79
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	220.55	288.11	15.90	18.88	1.99	4.97	7.95	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	176.39	262.20	4.77	19.07	0.00	4.77	0.00	19.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	231.85	264.46	16.60	23.13	0.00	10.67	2.96	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	226.63	307.05	17.06	24.37	1.22	3.66	3.66	7.31
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	162.31	270.52	27.05	27.05	0.00	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	264.75	295.79	19.00	20.90	1.27	6.97	3.17	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	193.15	212.46	10.35	11.04	0.00	7.59	2.76	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	191.28	236.41	8.60	6.45	2.15	8.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	191.61	199.59	7.98	11.98	0.00	7.98	7.98	11.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	172.19	216.96	10.33	10.33	0.00	0.00	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	187.03	233.07	6.93	9.37	1.22	6.93	2.44	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	231.18	238.33	8.74	13.51	0.00	7.94	2.38	5.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	180.98	219.30	7.07	8.25	0.00	2.95	2.95	4.13
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	186.71	189.83	6.23	7.79	0.00	4.99	1.87	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	157.73	203.17	5.35	6.68	0.00	1.34	1.34	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	238.90	313.41	7.10	9.46	15.37	8.28	16.56	10.64
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	228.55	277.34	15.41	23.11	7.70	0.00	15.41	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	252.64	311.16	13.08	6.20	15.83	8.26	19.28	4.13
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1522.03	1437.91	20.78	29.69	73.73	11.38	56.41	19.30
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	1328.99	1125.99	25.79	23.55	53.83	14.58	62.80	29.16
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1410.79	1277.85	26.08	22.90	76.33	12.09	34.98	22.26
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2931.30	2074.15	29.82	25.79	70.52	15.31	45.13	27.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2623.25	1894.93	34.89	23.99	74.14	10.90	63.24	34.89
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2703.90	1830.90	32.94	35.48	55.75	19.01	39.28	53.22
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1504.47	893.95	10.32	20.03	20.03	8.50	21.24	15.78
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	1292.43	854.09	18.08	0.00	31.63	9.04	31.63	49.71
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1298.94	801.44	9.06	16.47	23.06	8.24	21.42	14.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	498.84	401.61	6.55	6.75	15.48	6.35	15.28	6.55
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	734.98	651.58	11.03	11.68	18.50	7.79	14.28	9.09
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	660.07	551.08	11.20	10.19	12.22	9.17	15.28	10.19
mesodermal tumor cell line:HIRS-BM	10696-109G3	132.31	198.84	5.42	4.64	0.00	9.28	3.09	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	505.56	256.56	0.00	0.00	0.00	0.00	0.00	3.07
mesothelioma cell line:ACC-MESO-4	10494-107B8	173.99	233.99	82.94	54.91	0.70	28.96	8.11	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	371.80	196.59	64.10	25.64	0.00	8.55	12.82	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	220.40	115.80	32.06	18.08	0.51	10.17	6.47	1.75
mesothelioma cell line:Mero-25	10850-111F4	416.23	314.10	73.31	72.85	3.18	9.76	8.17	4.09
mesothelioma cell line:Mero-41	10851-111F5	652.26	629.52	0.73	0.49	1.47	4.65	2.44	4.16
mesothelioma cell line:Mero-48a	10852-111F6	422.49	355.40	12.40	15.50	1.11	3.99	1.55	3.76
mesothelioma cell line:Mero-82	10853-111F7	470.42	264.91	0.53	0.00	0.26	1.31	1.05	2.89
mesothelioma cell line:Mero-83	10854-111F8	298.91	237.80	17.02	11.23	1.19	5.45	3.57	1.87
mesothelioma cell line:Mero-84	10855-111F9	334.67	320.52	97.07	75.33	1.77	15.92	7.84	4.30
mesothelioma cell line:Mero-95	10856-111G1	449.28	326.51	28.99	17.18	0.62	12.22	3.52	2.69
mesothelioma cell line:NCI-H2052	10847-111F1	706.16	274.31	13.91	10.27	1.33	2.48	0.66	2.48
mesothelioma cell line:NCI-H226	10846-111E9	360.72	395.29	40.36	26.61	1.09	7.42	7.60	3.62
mesothelioma cell line:NCI-H2452	10848-111F2	297.40	387.42	112.06	87.63	0.68	14.01	11.10	3.42
mesothelioma cell line:NCI-H28	10845-111E8	1269.53	805.38	266.93	199.25	2.04	47.59	23.67	12.21
mesothelioma cell line:No36	10857-111G2	103.41	203.88	174.84	115.80	2.61	24.47	12.72	4.89
mesothelioma cell line:ONE58	10858-111G3	431.90	195.63	0.00	0.27	0.27	1.35	1.90	4.34
migratory langerhans cells, donor1	11901-125F2	117.26	193.65	20.54	19.96	0.38	3.84	0.58	2.11
migratory langerhans cells, donor2	11902-125F3	135.91	219.20	26.62	22.84	0.00	1.83	0.37	1.95
migratory langerhans cells, donor3	11903-125F4	105.18	191.86	21.90	21.90	0.00	3.95	0.36	2.15
mixed mullerian tumor cell line:HTMMT	10689-109F5	237.35	325.50	3.92	1.63	0.65	2.61	4.57	5.55
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	677.14	788.61	35.39	82.02	2.33	18.86	15.47	7.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	218.61	182.21	132.92	117.71	0.23	15.43	13.36	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	131.68	331.49	165.93	129.21	0.57	13.32	4.57	3.62
myelodysplastic syndrome cell line:SKM-1	10772-110F7	293.82	241.89	268.69	194.22	0.92	36.59	10.72	2.77
myeloma cell line:PCM6	10474-106I6	109.11	272.19	106.94	89.15	0.20	26.29	3.36	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	360.18	322.64	0.00	0.51	1.01	1.01	0.00	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	534.87	523.10	25.50	17.85	1.18	6.67	5.69	2.35
nasal epithelial cells, donor1, tech_rep1	12226-129F3	253.71	133.93	18.94	25.07	0.11	2.01	0.33	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	206.13	116.27	19.56	19.27	0.00	1.62	0.29	0.81
nasal epithelial cells, donor2	12227-129F4	526.05	218.59	22.63	23.74	0.00	1.10	0.00	2.76
neuroblastoma cell line:CHP-134	10508-107D4	108.13	83.51	20.25	56.13	0.00	56.13	5.75	0.92
neuroblastoma cell line:NB-1	10539-107G8	120.67	205.05	55.56	109.63	0.19	49.58	14.22	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	133.07	157.32	9.28	17.50	0.00	12.86	8.65	0.84
neuroblastoma cell line:NH-12	10555-107I6	148.89	149.27	42.49	76.59	0.00	61.87	12.67	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	176.26	91.81	11.62	32.74	0.24	43.65	3.56	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	351.60	280.18	79.35	62.24	0.00	70.95	44.19	5.70
neuroectodermal tumor cell line:TASK1	10774-110F9	192.20	159.80	29.59	31.80	0.60	57.96	36.03	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	425.96	228.24	8.26	19.71	0.00	39.42	11.44	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	618.04	662.75	37.00	38.86	0.53	12.78	7.72	6.39
neutrophil PMN, donor1	12133-128D9	461.12	14.87	14.87	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	424.98	185.93	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	681.89	217.82	9.47	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	368.34	152.04	174.36	159.82	0.00	41.27	6.93	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	333.01	222.54	161.70	66.44	0.00	8.81	4.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	274.44	435.06	24.37	14.75	1.28	4.17	3.85	8.02
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	256.20	536.83	55.44	26.01	1.31	10.77	5.26	5.26
nucleus accumbens, adult, pool1	10037-101F1	350.21	714.85	41.81	69.65	1.03	53.06	13.12	1.03
occipital cortex - adult, donor10196	10172-103C1	348.20	546.00	41.21	109.20	2.06	74.17	24.72	6.18
occipital cortex, adult, donor10252	10163-103B1	442.26	642.19	51.79	65.48	0.54	30.06	13.95	4.29
occipital cortex, newborn, donor10223	10355-105E4	266.77	446.92	20.02	28.39	3.28	28.75	13.83	5.46
occipital lobe, adult, donor1	10076-102A4	515.88	717.92	38.84	67.17	2.36	51.43	34.11	15.48
occipital lobe, fetal, donor1	10073-102A1	161.34	164.77	4.29	6.87	0.43	15.02	3.86	1.72
occipital pole, adult, pool1	10036-101E9	461.14	725.97	37.77	71.04	1.34	42.10	11.27	1.97
olfactory region, adult	10195-103E6	408.85	887.25	39.74	54.07	1.34	41.27	27.51	7.64
optic nerve, donor1	10277-104E7	488.26	246.13	20.01	18.01	0.00	16.01	10.01	14.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	236.13	118.12	78.37	68.57	0.46	12.64	2.05	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	348.27	254.03	59.90	105.65	0.41	14.29	3.30	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	416.03	109.38	0.00	0.17	0.00	0.00	0.17	2.54
oral squamous cell carcinoma cell line:SAS	10544-107H4	320.88	158.25	0.00	0.00	0.00	0.00	0.00	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	448.59	469.17	20.58	12.05	0.59	6.17	0.29	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	205.55	190.60	28.96	19.62	0.00	3.74	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	55.14	147.81	122.36	36.05	0.00	10.82	8.27	1.27
ovary, adult, pool1	10020-101D2	227.90	203.00	42.63	42.98	1.57	19.39	11.79	3.84
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	516.60	449.13	50.60	28.41	0.92	4.95	4.95	5.87
pancreas, adult, donor1	10049-101G4	249.27	139.21	37.63	60.20	0.00	22.58	6.58	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	668.09	154.30	21.80	26.00	0.00	9.22	2.52	3.91
papillary adenocarcinoma cell line:8505C	10437-106E5	349.56	248.89	0.00	0.00	0.00	0.85	0.17	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	235.29	73.19	19.37	17.22	0.17	4.14	2.15	0.66
paracentral gyrus, adult, pool1	10035-101E8	495.59	758.26	41.09	56.19	2.01	36.97	11.62	1.37
parietal cortex, adult, donor10258	10373-105G4	226.07	490.32	37.43	80.74	0.73	37.43	18.35	2.94
parietal lobe - adult, donor10196	10171-103B9	324.47	504.10	31.04	69.60	0.94	29.15	19.75	4.70
parietal lobe, adult, donor10252	10157-103A4	469.74	784.14	55.87	78.67	1.43	39.05	15.11	3.42
parietal lobe, adult, pool1	10034-101E7	481.57	697.91	37.19	59.66	1.50	35.78	13.22	1.32
parietal lobe, fetal, donor1	10072-101I9	179.42	174.57	2.91	14.55	0.00	40.73	7.76	0.97
parietal lobe, newborn, donor10223	10356-105E5	243.76	440.41	26.17	32.53	1.12	31.03	10.84	5.23
parotid gland, adult	10199-103F1	748.01	181.92	15.42	23.43	54.27	5.55	8.02	1.23
penis, adult	10200-103F2	429.15	750.88	113.33	87.01	4045.53	17.72	12.35	25.78
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	93.71	137.22	38.12	72.33	0.19	21.20	2.42	3.16
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	586.42	630.71	128.36	118.89	1.89	20.25	16.61	3.64
pineal gland - adult, donor10196	10179-103C8	305.74	306.39	7.10	15.48	3.23	36.12	26.45	1.29
pineal gland, adult, donor10252	10160-103A7	200.17	274.19	10.66	20.73	0.00	39.09	15.99	2.96
pineal gland, adult, donor10258	10377-105G8	381.89	309.77	11.91	20.07	3.14	80.27	55.18	1.25
pituitary gland - adult, donor10196	10180-103C9	265.09	183.14	44.52	109.27	10.12	29.34	21.25	1.01
pituitary gland, adult, donor10252	10162-103A9	225.67	134.99	35.96	80.26	0.52	19.28	7.30	1.56
pituitary gland, adult, donor10258	10378-105G9	294.53	225.58	81.72	137.90	2.55	45.12	47.67	1.70
placenta, adult, pool1	10021-101D3	272.09	176.41	11.07	11.50	0.32	4.41	3.12	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	232.41	334.64	294.78	178.25	0.00	22.12	5.16	2.65
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	525.28	417.58	40.78	26.15	0.00	8.56	5.45	4.05
pons, adult, pool1	10033-101E6	687.25	435.07	22.55	30.55	1.64	23.58	8.52	2.75
postcentral gyrus, adult, pool1	10032-101E5	518.78	874.81	40.97	71.40	3.84	41.67	25.11	3.05
promyelocytes/myelocytes PMC, donor1	12132-128D8	221.69	79.47	2.09	0.00	2.09	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	258.88	187.27	66.10	110.16	0.00	27.54	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	222.98	164.30	140.83	140.83	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	305.45	476.31	335.75	253.31	1.17	29.42	5.39	4.08
prostate cancer cell line:PC-3	10439-106E7	556.30	311.46	50.09	51.55	0.36	8.89	2.72	1.45
prostate, adult, pool1	10022-101D4	194.62	311.07	38.54	39.45	1.18	13.15	9.79	3.99
putamen, adult, donor10196	10176-103C5	276.43	978.01	72.24	135.50	0.71	88.76	31.40	3.07
putamen, adult, donor10252	10152-102I8	152.94	298.03	43.14	43.14	0.00	21.57	19.61	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	161.74	255.72	9.84	79.78	6.56	28.41	14.21	6.56
putamen, adult, donor10258, tech_rep2	10372-105G3	296.70	557.16	40.35	91.81	1.21	54.85	34.07	1.69
putamen, newborn, donor10223	10365-105F5	405.57	295.37	62.22	76.47	2.25	66.72	36.73	4.50
rectal cancer cell line:TT1TKB	10469-106I1	369.49	70.12	2.04	1.45	0.00	4.07	0.87	0.58
rectum, fetal, donor1	10067-101I4	322.71	166.92	11.13	6.95	2.78	5.56	8.35	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	454.10	373.75	106.64	98.58	1.06	19.29	7.84	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	601.85	424.98	38.11	20.30	0.00	10.77	1.24	0.83
retina, adult, pool1	10030-101E3	373.54	394.81	41.65	38.87	1.69	33.00	34.49	0.99
retinoblastoma cell line:Y79	10475-106I7	453.35	378.79	32.99	59.49	3.64	190.44	61.83	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	323.60	439.29	50.78	39.71	20.78	10.82	7.38	3.32
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	443.17	120.63	17.15	19.68	1.97	19.40	5.91	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	466.08	264.49	11.37	8.34	0.00	6.06	0.00	0.76
salivary acinar cells, donor1	11771-123I7	241.00	290.53	16.99	13.92	0.00	5.50	1.46	0.65
salivary acinar cells, donor2	11772-123I8	266.84	289.56	7.71	10.46	0.14	6.75	1.38	1.79
salivary acinar cells, donor3	11773-123I9	224.44	198.62	0.00	3.97	0.00	3.31	1.32	1.99
salivary gland, adult, pool1	10093-102C3	662.89	156.14	26.88	25.74	31.46	7.44	5.15	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	251.42	272.33	28.58	19.73	0.59	3.71	1.43	1.77
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	267.67	298.58	27.86	24.69	0.24	4.94	0.82	1.29
seminal vesicle, adult	10201-103F3	474.05	399.98	37.56	35.98	2.65	16.93	3.17	5.29
serous adenocarcinoma cell line:JHOS-2	10639-108I9	329.16	195.80	12.39	9.96	1.70	2.67	1.46	4.86
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	1319.81	442.12	13.84	10.32	0.25	11.58	5.54	6.54
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	1146.03	574.02	10.04	6.02	0.00	10.04	4.01	8.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	385.23	268.37	39.49	39.76	0.13	26.86	11.28	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	340.43	229.46	15.03	20.23	0.11	2.98	1.44	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	349.92	423.85	150.70	191.34	0.52	30.32	8.52	2.58
skeletal muscle - soleus muscle, donor1	10282-104F3	1210.13	1338.52	146.12	209.96	4119.82	19.86	41.14	41.14
skeletal muscle, adult, pool1	10023-101D5	1109.18	1778.43	315.79	380.44	2747.88	35.86	60.45	38.74
skeletal muscle, fetal, donor1	10066-101I3	1324.61	1050.24	81.41	69.35	2108.52	11.06	21.11	22.11
skin, adult, donor1	10074-102A2	726.02	264.62	20.36	13.57	0.00	6.79	0.00	13.57
skin, fetal, donor1	10065-101I2	286.58	259.43	29.04	31.56	216.51	10.10	4.42	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	154.09	188.11	27.68	52.03	2.00	19.68	12.01	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	110.01	168.95	93.30	97.40	0.32	14.81	12.61	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	260.59	321.12	7.90	23.71	0.00	6.17	1.35	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	219.06	141.75	31.81	49.45	0.16	23.24	3.96	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	707.90	231.14	29.44	69.49	1.13	110.18	27.34	1.77
small cell lung carcinoma cell line:WA-hT	10562-108A4	115.28	237.31	127.92	97.63	2.83	14.82	12.20	2.18
small intestine, adult, pool1	10024-101D6	509.07	225.63	14.45	15.17	0.12	5.85	2.15	7.76
small intestine, fetal, donor1	10064-101I1	249.38	125.31	6.88	15.72	0.00	6.14	1.97	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	126.17	447.25	137.97	82.58	0.51	14.36	8.72	6.67
smooth muscle, adult, pool1	10048-101G3	139.31	514.58	37.73	40.06	1.29	10.86	5.43	1.03
somatostatinoma cell line:QGP-1	10781-110G7	125.97	357.81	96.76	55.21	0.27	6.97	5.09	1.07
spinal cord - adult, donor10196	10181-103D1	536.12	238.12	27.99	29.13	2.52	21.33	13.76	2.06
spinal cord, adult, donor10252	10159-103A6	221.97	148.64	32.33	40.61	0.39	20.90	7.89	0.39
spinal cord, adult, donor10258	10369-105F9	259.42	151.50	39.43	41.51	4.84	10.38	13.14	4.15
spinal cord, fetal, donor1	10056-101H2	369.56	251.25	14.64	20.73	9.15	10.98	3.66	3.66
spinal cord, newborn, donor10223	10359-105E8	320.53	154.30	49.14	28.93	2.30	16.99	11.48	5.97
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	429.54	668.36	37.64	28.97	0.60	8.21	8.51	2.84
spleen, adult, pool1	10025-101D7	182.05	179.19	37.12	46.81	0.22	13.22	2.86	1.21
spleen, fetal, pool1	10044-101F8	191.41	153.11	34.88	40.28	0.24	11.20	5.64	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	214.17	377.30	328.13	186.74	1.14	62.83	18.63	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	420.95	205.45	24.87	28.67	0.19	9.68	1.33	1.90
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	291.44	473.51	55.56	34.25	1.75	5.24	3.49	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	662.24	144.64	0.00	0.00	0.39	0.00	0.39	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	455.41	246.95	1.13	0.79	0.68	4.39	1.24	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	429.53	396.07	413.01	325.33	0.85	59.73	52.53	5.93
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	250.46	249.61	8.04	8.46	0.42	1.69	0.42	1.69
stomach, fetal, donor1	10062-101H8	410.10	175.15	13.88	20.29	0.00	4.27	1.07	0.00
submaxillary gland, adult	10202-103F4	630.07	180.59	21.08	25.07	203.95	9.11	11.96	2.28
substantia nigra - adult, donor10196	10178-103C7	271.37	108.55	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	303.25	246.75	58.16	62.73	1.66	23.06	14.75	1.66
substantia nigra, adult, donor10258	10371-105G2	341.39	304.66	41.90	59.48	5.69	24.31	14.48	3.10
substantia nigra, newborn, donor10223	10358-105E7	332.09	131.42	35.33	21.20	2.12	15.54	5.65	4.24
synovial sarcoma cell line:HS-SY-II	10441-106E9	248.29	328.77	62.13	94.92	0.46	24.53	3.44	2.52
temporal lobe, adult, pool1	10031-101E4	511.42	1019.79	46.12	79.43	1.86	53.24	20.01	2.80
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	106.84	200.15	2.85	5.70	0.00	24.93	3.56	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	111.20	192.08	8.79	7.47	0.00	14.07	1.76	1.76
tenocyte, donor1	11763-123H8	311.40	355.04	40.50	33.16	0.35	6.63	2.09	2.09
tenocyte, donor2	11765-123I1	330.38	328.86	12.97	11.06	0.38	3.43	2.29	1.53
tenocyte, donor3	11768-123I4	295.42	382.16	17.42	17.79	1.11	2.97	1.85	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	295.05	147.87	13.77	28.04	0.34	21.42	4.25	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	169.72	113.92	55.80	59.19	4.16	43.62	31.60	1.23
teratocarcinoma cell line:PA-1	10807-111A6	573.57	340.95	78.42	130.49	0.31	43.08	18.60	4.80
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	472.75	430.48	44.94	43.16	0.63	35.29	21.45	8.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	726.09	359.64	31.01	61.26	0.00	33.66	3.40	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	271.13	125.31	13.74	19.30	0.11	18.43	4.47	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1534.71	403.55	40.06	54.07	1.63	23.12	9.12	12.38
testis, adult, pool1	10026-101D8	149.78	239.55	23.30	19.33	0.43	6.55	2.47	3.97
testis, adult, pool2	10096-102C6	130.81	165.10	13.53	14.43	1.35	4.51	0.45	1.35
thalamus - adult, donor10196	10168-103B6	333.40	338.92	37.54	49.68	0.00	30.91	22.08	3.31
thalamus, adult, donor10252	10154-103A1	301.31	296.94	49.39	52.35	1.09	29.54	12.66	2.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	240.18	284.83	21.55	43.11	12.32	13.86	6.16	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	614.62	364.62	26.68	25.03	2.47	21.90	15.65	5.27
thalamus, newborn, donor10223	10366-105F6	450.48	449.32	32.22	14.96	3.45	33.37	23.01	6.90
throat, adult	10209-103G2	709.31	794.45	140.31	111.60	1986.37	15.48	19.72	14.48
throat, fetal, donor1	10061-101H7	378.14	351.33	50.58	42.96	413.79	10.36	17.06	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	330.09	296.31	16.69	29.61	0.20	14.71	2.19	1.39
thymus, adult, pool1	10027-101D9	209.17	180.84	60.84	96.13	0.20	33.60	3.08	2.68
thymus, fetal, pool1	10043-101F7	230.77	155.13	48.94	68.16	0.42	23.38	3.53	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	364.45	247.04	16.75	9.17	0.93	5.58	4.39	2.53
thyroid carcinoma cell line:TCO-1	10783-110G9	365.71	346.71	66.49	31.29	0.14	10.48	6.01	1.96
thyroid, adult, pool1	10028-101E1	242.71	222.27	78.48	62.05	22.21	18.57	6.25	3.17
thyroid, fetal, donor1	10060-101H6	386.27	328.00	66.44	39.55	86.75	17.40	13.71	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	785.30	520.46	21.56	36.96	360.32	9.24	6.16	6.16
tongue, adult	10203-103F5	1031.48	1094.97	191.18	144.66	2016.91	16.05	20.00	22.09
tongue, fetal, donor1	10059-101H5	1177.16	963.95	239.61	202.96	1919.23	17.34	49.26	13.01
tonsil, adult, pool1	10047-101G2	507.79	318.66	49.49	68.52	76.23	10.72	2.60	1.30
trachea, adult, pool1	10029-101E2	385.35	347.89	65.77	62.17	21.92	9.33	5.24	3.68
trachea, fetal, donor1	10058-101H4	546.65	329.68	56.93	56.93	305.06	11.93	6.16	3.85
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	486.77	629.55	39.32	25.15	0.00	5.31	5.67	3.90
transitional-cell carcinoma cell line:5637	10418-106C4	254.61	74.97	3.65	3.34	0.10	7.50	2.23	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	173.45	131.93	69.26	98.24	0.47	22.72	4.23	2.19
tridermal teratoma cell line:HGRT	10694-109G1	996.93	321.53	9.51	3.81	0.00	5.71	0.00	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	286.03	249.89	43.59	39.96	0.59	10.84	5.25	1.61
umbilical cord, fetal, donor1	10057-101H3	312.98	490.33	106.41	47.99	50.08	10.43	4.17	0.00
uterus, adult, pool1	10100-102D1	101.69	183.43	26.62	39.42	0.34	10.24	3.41	0.85
uterus, fetal, donor1	10055-101H1	457.15	326.61	34.30	36.35	2.05	12.80	4.61	2.56
vagina, adult	10204-103F6	350.89	183.52	29.08	31.02	0.65	9.69	3.23	3.23
vein, adult	10191-103E2	220.95	259.75	36.61	46.47	117.27	13.59	5.04	3.07
xeroderma pigentosum b cell line:XPL 17	10563-108A5	212.56	415.24	174.11	170.37	0.27	25.90	8.81	2.94